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Research Experience for Undergraduates 
University of Arkansas 
 
 
 The University of Arkansas Department of Chemistry and Biochemistry hosted a 
National Science Foundation sponsored Research Experience for Undergraduates (REU) summer 
program for the 23rd year.  The department first hosted an REU in 1959.  The 10-week summer 
program, funded by the National Science Foundation, allowed students an opportunity to gain 
hands-on experience in a chosen research area while introducing them to careers in scientific 
research in areas including analytical chemistry and sensor technology, biochemistry and protein 
dynamics, inorganic chemistry and nanotechnology, organic chemistry, and physical and 
theoretical chemistry. 
 
 Undergraduate chemistry majors, who were sophomores or juniors in fall 2010, applied 
to the program, which took place at the University of Arkansas, Fayetteville. 
 
 Outside the lab, students met each week to hear presentations from campus experts about 
topics ranging from how to get into graduate school and test-taking skills to ethics, and how to 
make a poster presentation.  A number of social activities took place throughout the summer to 
give students a chance to interact. 
 
 Selected students received a scholarship to pay for room and board and an allowance to 
attend a regional or national chemical conference in the 2011-2012 academic year.  Students 
involved in the program were enrolled as students at the U of A and received one hour of 





Tony Jude Award 
 
Mississippi native Edward Evans, Jr. was the recipient of the Tony Jude Award for his summer 
research.  He is a student at Wabash College in Indiana.  The Tony Judy Award was created in 
2002 to recognize a student for outstanding research.  It is awarded in memory of a former REU 
student who returned to the University of Arkansas and obtained a doctorate degree. 
 
 Ed,  under the direction of Professor Paul Adams, presented a poster entitled “Expression 
and Purification of Cdc42 and PBD46, an Important Ras-Protein Complex.”   
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Protein-Protein Interactions in Photosynthesis: Structure-Function 
Relationships in Electron Transfer Proteins 
 
Ingrid Fritsch  
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Microelectrochemical detection and microfluidics for lab-on-a-chip 
applications: protein, DNA, and microorganism analysis 
 
Denise Greathouse 
Research Assistant Professor 
Characterization of structure and peptide-lipid interactions of 










Development of Nanocrystals for Biophysical Applications 
Roger Koeppe  
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Total Synthesis of Biomedically Significant Complex Natural 
Products 
 
Frank Millett  
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Measurement of Chemical Communication (Signaling) molecules, 
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In Vivo Chemical Analysis 
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human thrombomodulin in disease. 
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Matrix-assisted Laser Desorption Fourier Transform Mass 
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	 	 	 	 Meet	in	Ballroom	with	campus	ambassadors	
2:30	p.m.	–	4:30	p.m.	 Departmental	Logistics	
Place:		Chemistry	Building	Room	105	
	 	 	 	 Meet	your	Mentor:	Refreshments	will	be	served	









12:00	noon	 	 	 Go	to	Your	Lab	and	Get	Started!	
	
Wednesday,	May	25	 	
8:00	a.m.	 	 	 Report	to	your	lab	
	
5:30	p.m.	–	7:00	p.m.	 Dinner	&	Dialogue	





1:00	p.m.	 	 	 CHEM	105	













	 	 	 	 Location:		Devil’s	Den	State	Park	(bring	swim	suit!)	
	
Friday,	June	3	 	 REU/INBRE	Group	Meeting	
1:00	p.m.	 	 	 CHEM	105	





	 	 	 	 	
Wednesday,	June	8	 	 Dinner	&	Dialogue	
5:30	p.m.	–	7:00	p.m.	 Location:		Alumni	House	
	 	 	 	 Speaker:		Brady	and	Grady	Wright	




	 	 	 	 Location:		The	Gardens	
	
Friday,	June	10	 	 REU/INBRE	Group	Meeting		
1:00	p.m.	 	 	 CHEM	105	
	 	 	 	 Speaker:		Jack	Lay	












1:00	p.m.	 	 	 CHEM	105	
	 	 	 	 Speaker:		Dr.	Colin	Heyes	






	 	 	 	 Speaker:		Dr.	Lynn	Meade	
	 	 	 	 Topic:			How	to	Give	an	Effective	Presentation	
	 	 	 	 	
Thursday,	June	23	 	 Evening	Entertainment	
6:00	p.m.	–	9:00	p.m.	 Host:		CeMB	
	 	 	 	 Location:		Razorback	Malco	Theater	
	 	 	 	 	
Friday,	June	24	 	 REU/INBRE	Group	Meeting	








10	a.m.	 	 	 Location:		MEEG	Auditorium	‐	Testing	is	FREE	 	
	 	 	 	 Participation	requires	pre‐registration	 	
	
Mon‐Tues,	June	27‐28	 NCTR	Tour	
	 	 	 	 Jefferson,	AR	




	 	 	 	 Speaker:		Alfred	Dowe	&	Vicky	Hartwell	













	 	 	 	 You	must	return	to	Fayetteville	by	8:00	a.m.,	July	5	
	
Friday,	July	8	 	 INBRE	student	presentations		
10:30	a.m.	 	 	 Access	Grid	–	Mullins	Library	
	
1:00	p.m.	 	 	 REU/INBRE	Group	Meeting	
	 	 	 	 CHEM	105	








11:00	a.m.	 	 	 Access	Grid	–	Mullins	Library	
	
1:00	p.m.	 	 	 REU/INBRE	Group	Meeting	
	 	 	 	 CHEM	105	
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	 	 	 	 Speaker:		Ingrid	Fritsch	
	 	 	 	 Topic:		From	Research	to	Commercialization	
	
Friday,	July	22	 	 INBRE	student	presentations		
10:30	a.m.	 	 	 Fayetteville	Students	presenting	‐	Access	Grid	–	Mullins	
Library	
 
1:00	p.m.	 	 	 REU/INBRE	Group	Meeting	
	 	 	 	 Chem	105	
David	Paul	‐	How	to	Make	a	Poster	
Thursday,	July	28	 	 Meeting	in	Miniature,	Lunch	Served	
10:00	a.m.					 	 	 CHEM	105	
	 	
Friday,		July	29	 	 End	of	Program	







Phospholipid Analyses Utilizing GC-MS 
Terry Anderson, Philander Smith College 




 Phospholipids such as Phosphatidylcholine, are some of the most abundant lipids 
found in nature. These lipids are able to be analyzed by using the GC-MS, although the 
method for analysis is not as efficient. In this study a more efficient process of analysis for 
phospholipids was developed with possible application to tissue analysis. Utilizing an 
esterfication process to transform the lipids from a non-volatile state to a volatile state for 
GC-MS analysis. The phospholipids Phosphatidylcholine & Phosphatidylinositol were 
found to form FAMES better with a basic catalyst such as NaOCH3. Whereas a 
phospholipd such as Sphingomyelin was able to use an acidic catalyst such as BF3 to create 
FAMES. When standard samples were run with multiple test a Relative Standard 
Deviation (RSD) of below 1%. When a beef tissue sample  underwent lipid extraction the 
sample was used in the developed protocols. The tissue lipids were identified and resulted 




 A GC-MS is two part Instrument, A) a Gas Chromatograph (GC) for separating volatile 
compounds; and B) a Mass Spectrometer (MS) for analyzing the mass-to-charge ratio of the 
substances exiting the GC. 
 The purpose of this research was the development of proper analytical methods and their 
applications to tissue samples to properly profile the phospholipids. The only way to profile 
lipids in a GC-MS is an esterfication process which is necessary to make the lipid more volatile, 
or as a Fatty Acid Methyl Ester (FAMES) to move through the GC-MS column.  A tissue 
extraction process has to be performed to obtain the lipids. Then esterfication process must be 
done on the extract. 
  The lipids that were used in this project: Phosphatidylcholine(PC), 
Phosphatidylnostiol(PI), are of the glycreophospholipids lipid classification, and 
Sphingomyelin(SM) of the sphingolipids lipid classification, are some of the most abundant 

























GC-MS Lipid Standard Fatty Acid Methyl Ester's (FAMES) Preparation: 
 
 Weigh 2mg of standard lipid sample into a 16 X 125 mm Pyrex screw cap culture tube. 
Next, add 2 ml of BCl3-methanol 12% (w/w)*.  Then heat the test tube in a hot water bath for  5-
10† min, at 60 C. Afterwards remove the test tube from heat and allow to cool for 10 min, before 
adding 1 ml of Distilled water and 1 ml of Hexane.  Agitate the mixture, then allow the layers to 
partition apart. Remove the top organic layer and dry the layer in a separate vial of anhydrous 
sodium sulfate. Allow layers to form again, remove the top layer, noting only to remove the top 
liquid layer, no solid particles. Place this layer into a GC vial for storage at -20°C. 
 
GC-MS Lipid Standard Mixture Fatty Acid Methyl Ester's (FAMES) Preparation: 
 
 Weigh .25mg of PC & SM sample, and 25 ul of PI in to a 16 X 125 mm Pyrex screw cap 
culture tube. Next add, 2 ml of BCl3-methanol 12% (w/w)*.  Then heat the test tube in a hot 
water bath for 1.5hrs, at 60 C. Afterwards remove the test tube from heat and allow to cool for 10 
min, before adding 1 ml of Distilled water and 1 ml of Hexane.  Agitate the mixture, then allow 
the layers to partition apart. Remove the top organic layer and dry the layer in a separate vial of 
anhydrous sodium sulfate. Allow layers to form again, remove the top layer, noting only to 
remove the top liquid layer, no solid particles. Place this layer into a GC vial for storage at -20 C. 
 
GC-MS Tissue Lipid Extraction & FAMES Preparation: 
 
 Take freeze-dried tissue sample and grind it in a blender for 10-15s at room temperature. 
Next .5g of the tissue sample is placed into a 16 X 125 mm Pyrex screw cap culture tube. Next, 
680 ul of Chloroform and 340 ul MeOH (in a 2:1 vol/vol) are added to the sample. Following 
this, 2 ml of BCl3-methanol 12% (w/w)*.  Then heat the test tube in a hot water bath for  1.5 hrs, 
at 60 C with vigorous handshaking for every 5's, every 20 min. Afterwards remove the test tube 
from heat and allow to cool for 10 min, before adding  2 ml of saturated  NaHCO3 and 3 ml of 
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Hexane. Vortex the mixture, then centrifuge the mixture for 30 sec. Remove the hexane layer 
and dry the layer in a separate vial of anhydrous sodium sulfate and Potassium Carbonate (10:1 
wt/wt).   Allow layers to form again, remove the top layer, noting only to remove the top liquid 
layer, no solid particles.  Place this layer into a GC vial for storage at -20°C. 
 
GC-MS Temperature Gradient Method 
 
 Utilizing a Varian 320 Triple Quadrupole GC-MS the machine was set at an initial 
temperature of 140°C, with a 5 min. hold.  The temperature was then set at an increasing rate of 
4°C/min to 240°C with a 15 min hold.   
 
Results & Discussions  
 
FAMES Catalyst Comparison: 
 
 When the catalyst BF3 was used in FAME procedure unique results followed regarding 
the type of lipid that was used in the process.  Gylcerophospolipids such as Phosphatidylcholine 
(PC) (Fig. 2-1) when used with the BF3 procedure produced minimal FAMES with a decrease in 
signal to noise ratio, and a reduced ion count.  When utilizing NaOCH3 in the FAME procedure 
the exact opposite occurs with a minimal amount of noise present in the GC-MS run. Ion counts 
for the sample also increase dramatically when the base catalyst is used.  The finding also applies 



















































Although this is not the case for the sphingolipids lipid type, such as Sphingomyelin (SM) (Fig. 
2-3) which has a better FAME creation with BF3 than with NaOCH3.  Because of this all lipids 
























Figure 2-2. Phosphatidylinositol(PC) catalyst comparison for FAMES preparation.  
SM/BF3 
SM/NaOCH3 
Figure 2-3. Sphingomyelin(SM) catalyst comparison for FAMES preparation.  
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Lipid Standard FAMES Identification: 
  
 The FAMES of the standard lipid were identified based off of the possible methyl ester 
that created from the fatty acids of the lipid.  For PC & PI two major FAMES were identified 
(Table 1-1,2) in correspondence to the structure provided.  Multiple test runs under the same 
conditions were run with all lipid standards.  This resulted in a relative standard deviation (RSD) 
at the retention time of each respective lipid to be below 1%.  The standard lipid SM, on the 
other hand only had one major FAME that was identified (Table 1-3).  This lipid was also run 
under the same conditions multiple times, and also resulted in an RSD of below 1%. 
 
 












methyl, methyl ester 
C17H36O2 272.2715 16:1 0.03% 
23.553 ± 
0.0085 
15-Octadecanoic Acid, methyl 
ester  

















C21H38O2 322.5315 20:2 0.03% 
24.147 ± 
0.0067 
Octadecanoic Acid, methyl 
ester 















Hexadecanoic Acid, methyl 
ester 





Table 1-1. Phosphatidylcholine(PC) FAME ID Table. 
Table 1-2. Phosphatidylinositol(PI) FAME ID Table.  
Table 1-3. Sphingomyelin(SM) FAME ID Table.  
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Lipid Standard Mixture FAMES Identification: 
 
 When the lipid standards were used in a combination that underwent the FAMES creation 
process, as previously done singularly each FAME was identified based off of the carbon length 
and retention time placement (Table 2-1, 2). Only two FAMES per catalyst were identifiable: 
SM & PC with the BF3 catalyst; and PC & PI with the NaOCH3 catalyst.  This is unique in the 
fact that it can show a potential interaction between the lipids that had not previously been seen 
before. 
 











Hexadecanoic Acid, methyl 
ester 
C17H34O2 270.2559 16:0 0.03% SM 
23.552 ± 
0.0148 
15-Octadecanoic Acid, methyl 
ester 























Octadecanoic acid, Methyl 
Ester 






  Using Ground Beef tissue, the lipid extraction process succeeded in removing the lipids 
from tissue for FAME esterfication. Utilizing both catalyst on the extracted lipids FAMES were 
created for analysis by GC-MS. Many FAMES were found to be present with in the test sample, 
but due to the retention time placement, and carbon length of particular FAMES a comparison to 
the lipid standards was done. With the BF3 sample a maximum of two FAMES were identified to 
have possible come from SM & PC (Table 3-1), with other FAMES from other lipids being 
found present with in the sample, but with no standard to identify these particular FAMES. This 
was not the case with the tissue lipid extracts with NaOCH3, where a majority of the FAMES 
that were identified as being PC with only one peak being identified as PI, none as SM(Table 3-
2). Although just as the BF3 sample there were other FAMES from lipids that were present 
within the sample tested that could not be identified due to a standard not being available to 
compare the retention time and carbon length. 
 
Table 2-1. Mixture with BF3 FAME ID Table.  
Table 2-2. Mixture with NaOCH3 FAME ID Table.  
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acid, methyl ester 
C19H36O2 
 

























































































 In conclusion, the GC-MS data showed that the FAME synthesis procedure worked in 
creating methyl esters, for GC-MS analysis.  The NaOCH3 catalyst being the better catalyst when 
trying to analyze, PC & PI, whereas BF3 is the better catalyst when trying to analyze SM with the 
Table 3-1. Tissue with BF3 FAME ID Table.  
Table 3-2. Tissue with NaOCH3 FAME ID Table.  
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GC-MS, to obtain the least amount of noise within the chromatogram.  The lipid extraction from 
the beef tissue was successful, with the NaOCH3 showing more lipids FAMES for identification 
from standard comparison, than BF3.  Due to the fact that the Relative Standard Deviation (RSD) 





 I would like to acknowledge the following people for helping with this research project.  I 
have learned many things from you all this summer and hope to carry all of this information with 
me for a long time to come: 
 
Beth Emerson 
Dr. Jennifer Gidden 
Dr. Frank Hahn 
Dr. Jack Lay 
Dr. Julie Stenken 
Dr. Rohana Liyanage 
I would also like to acknowledge the National Science Foundation CHE-0851505/REU and the 
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Fluorescence Labeling of cpSRP43 to Monitor the Protein  
Structure by Single Molecule FRET 
Jasmine Brown, Philander Smith College 




Various studies have been conducted to determine the structural changes of 
chloroplast protein signal recognition particle 43 (cpSRP43) upon its interaction with 
chloroplast protein signal recognition particle 54 (cpSRP54). These two proteins form a 
heterodimer which transport the light harvesting chlorophyll binding proteins to the 
thylakoid membrane to be used in photosynthesis. In this research, several methods were 
used to optimize the fluorescence labeling of cpSRP43 with the dyes alexa488 and alexa546. 
We used ensemble and single molecule Förster resonance energy transfer (FRET) to 
determine the structural changes during the interaction between cpSRP43 and cpSRP54. 
We were successful in establishing a labeling protocol that increased the concentration of 





Plants are efficient in converting sunlight into chemical energy which is essential for 
every form of life. There are various proteins in the chloroplast that are responsible for 
generating chemical energy. In our research, we are interested in the cpSRP43 and cpSRP54 
proteins. cpSRP are chloroplast protein signal recognition particles that are used to transport light 
harvesting chlorophyll a and b binding proteins to the thylakoid membrane (LHCP) (Stengel, 
Holdermann, Cain, Robinson, Wild, & Sinning, 2008).  cpSRP is formed by a combination of 
chromodomains and ankyrin domains (Stengel, Holdermann, Cain, Robinson, Wild, & Sinning, 
2008) (see figure 1). The cpSRP43 has four ankyrin sequential repeats that are involved in 
protein-protein interactions and complex formation (Cain, Holdermann, Sinning, Johnson, & 




There are two 
chromodomains CD2 and 
CD3 which are located at the 
C-terminal of the protein 
(Cain, Holdermann, Sinning, 
Johnson, & Robinson, 
2011).There is one 
chromodomain CD1 that is 
located at the N-terminal 
(Cain, Holdermann, Sinning, 
Johnson, & Robinson, 2011). 
cpSRP43 is also reported to 
serve as a chaperone that 
reverses the aggregation of its 
substrates’ proteins (Jaru-
Ampornpan, et al., 2010). 
The actual structure of 
cpSRP43 and cpSRP54 is 
unknown although structures 
of the individual CD1-Ank4, 
CD2 and CD3 have been 
deposited in the protein data 
bank as 3DEO, IX3P, and 
IX3Q, respectively. The SRP 
in cpSRP is a signal 
recognition particle, cyto-
plasmic ribonucleoprotein 
that mediates GTP dependent 
co-translational targeting of 
proteins to the endoplasmic 
reticulum (Schuenemann, et 
al., 1998). The concentration 
of cpSRP43 controls the 
partitioning of cpSRP54 
between co-translational and 
post-translational mode of 
targeting proteins in the 
chloroplast (Kathir, et al., 
2008). The LHCPs of the thylakoid membrane are part of a hydrophobic family of proteins 
involved in photosynthesis (Schuenemann, et al., 1998). LHCPs are part of the photosystem I 
and II and are synthesized in cytosol (Cain, Holdermann, Sinning, Johnson, & Robinson, 2011).  
The objectives for this research were to examine the structural changes of cpSRP43 upon 
interaction with cpSRP54 to gain an understanding of how the cpSRP43 and cpSRP54 
heterodimer binds to LHCP to transport it to the thylakoid membrane to be used in 
photosynthesis. By understanding the transport mechanism our goal is to hopefully have an 
K F Stengel et al. Science 
2008;321:253‐256  (3DEO in 




impact on the development of efficient solar energy devices. We would like to understand how 
plants are capable of efficiently producing chemical energy from sunlight in particles how they 
transport and insert the photosynthetic proteins. In this project, two mutant proteins were used in 
the experiments. For one of the proteins, we labeled the ankyrin 2 and chromodomain 3 and is 
referred to as protein 1 (P1). The other protein we labeled ankyrin 2 and chromodomains 2 and is 




Materials used for this research includes alexa488 maleimide (donor dye), alexa546 
maleimide (acceptor dye), HKM buffer (Hepes, Potassium chloride, Magnesium chloride), PBS 
buffer (Phosphate Buffered Saline), nano-pure water, Econo-column, Bio-gel P-6DG gel, urea, 
cpSRP43, cpSRP54, and TCEP (Tris (2-carboxyethyl) phosphine). The equipment that was used 
included the Ultraviolet visible spectrophotometer, fluorescence spectrometer, and the 
Fluorescence microscope. The ultraviolet visible spectrophotometer measures the absorbance so 
that the concentration of the donor and acceptor dyes relative to the protein concentration can be 
determined to quantify the labeling efficiency. The fluorescence spectrometer is used to measure 
the average fluorescence resonance energy transfer (FRET) for the sample (Skoog, Holler, & 
Crouch, 2007). The fluorescence microscope is used to measure the single molecule FRET. 
There were a series of experiments that were performed in order to optimize the labeled protein 
that was used to determine single molecule Förster resonance energy transfer. 
Protein Unfolding. The cpSRP43 was unfolded using urea concentration ranging from 0 
molar to 8 molar. By conducting the unfolding experiments, the data revealed which urea 
concentration could be used to unfold the protein so that the two cysteines can be exposed to the 
fluorescent dyes for attachment. The urea was diluted in HKM buffer making an 8.6M stock urea 
solution. It was added to a solution that contained the protein and HKM buffer. The stock 
concentration of the protein was 4mM. The table below shows the how much of each solution 

















1 2.5  0 97.5 100 0 
2 2.5  12.5 85 100 1.08 
3 2.5 25 72.5 100 2.16 
4 2.5 37.5 60 100 3.24 
5 2.5 50 47.5 100 4.32 
6 2.5 62.5 35 100 5.40 
7 2.5 75 22.5 100 6.48 
8 2.5 87.5 10 100 7.56 
 
 
Labeling cpSRP43 proteins.  Proteins 1 and 2 were labeled with thiol reactive ATTO 
labels (maleimides). The fluorescent dyes that were used were alexa488 and alexa546 




added 10 micro liters of 10x PBS buffer, 5 micro liters of TCEP reagent, and 47.5 micro liters of 
nano-pure water to an eppendorf tube. TCEP is used to ensure the thiol remains as its reduced 
(SH) form. After the solution has been mixed, the protein is added to the solution. After allowing 
the solution to react for ten minutes, we added the 2.5 micro liters of 1mM alexa546 and 5 micro 
liters of 1mM alexa488. The mixture was covered with aluminum foil to protect it from any 
source of light in the room and allowed to react overnight. This method was repeated several 
times with different dye concentrations, time elapsed between adding the alexa546 and alexa488, 
and the addition of urea to unfold the protein to increase labeling. The maleimide chemistry 
(figure 2) and labeling protocol (table 2) is shown in the figures below. 
 






    
 
 



















Components Method 1 Method 2 Method 3 Method 4 
Alexa546 
Concentration 
1 mM 3 mM 3 mM 3 mM 
Alexa488 
Concentration 
1 mM 1 mM 3 mM 3 mM 






0 hours 2 and 6 hours 1 hour 1 hour 
 
  
Gel filtration. A gel column is used to separate proteins, peptides, and oligonucleotides based on 
size (Gel Filtration Chromatography, 2011). The smaller molecules are trapped in the gel while 
the larger molecules move quickly through the column (Gel Filtration Chromatography, 2011). 
We used HKM buffer, Bio-gel, and Econo-column. The Bio-gel was packed into a glass econo-
column using the eluent, HKM buffer. The sample was added to the top of the Bio-gel and eluted 
down the column. The sample separated into two distinct bands. The first band contained the 
labeled proteins while the second band contained the excess dyes. Fractions were collected from 
the column as the sample was filtered through the gel. The first band was collected in an 
eppendorf tube and separated from the excess fluorescent dye band. The formation of the bands 





Fluorescence and absorbance spectra. The fluorescence and absorbance is measured 
and recorded for each fraction using the fluorescence spectrometer (Perkin Elmer LS-50) and 








as the baseline when the absorbance was measured. The parameters for measuring the 
absorbance included start at 800 nanometers, end at 200 nanometers, and a speed of 600 
nanometers per second. The absorbances were recorded at 280 nm for the protein, 499 nm for the 
donor dye, 558 nm for the acceptor dye, and 700 nm for the background. From these 
absorbances, the labeling ratio was calculated. 
 
To calculate the labeling ratio we used the following equation: 
 
 
A is the absorption that is measured at wavelengths 280 nm for the protein, 499 nm for the donor 
dye, and 561 nm for the acceptor dye. The epsilon is the extinction coefficient for each species. 
The epsilon value for the protein at 280 nm is unknown but estimated to be about 
20,000 .  For the donor at 499 nm, the epsilon value is 71,000 . For the 
acceptor at 561 nm, the epsilon value is equal to 104,000 . B is the length of the 
cuvette, 1 cm. 
 To calculate the labeling ratio, we collected the absorption values for the wavelengths. 
The absorption values at 280nm, 499nm, and 561 nm are corrected using the background 
absorption value from the wavelength of 700 nm due to spectral overlap. The alexa488 
absorption is corrected by subtracting 15% of the alexa546 absorption at 561 nm. Protein 
absorption is corrected by subtracting 14% of alexa546 absorption at 558 nm and 12% of 
alexa488 absorption at 499 nm.  
The fluorescence spectrometer was used to measure the protein, donor fluorescence, and 
acceptor dye fluorescence for the sample. It is used to calculate the average FRET for a sample 
using the following equation. 
 
 
 The fluorimeter can also be used to determine the protein unfolding monitoring the 
tryptophan fluorescence. The parameters for the tryptophan fluorescence included start at 300 
nm, end at 500 nm, excitation at 280 nm, scan speed at 200 nm per second, excitation slit at 10 
nm, and the emission slit at 10 nm. The donor dye parameters included start at 505 nm, end at 
700 nm, excitation at 485 nm, scan speed at 300 nm per second, excitation slit at 10 nm, and 
emission slit at 10 nm. The acceptor dye parameters included start at 560 nm, end at 700 nm, 
excitation at 540 nm, scan speed at 300 nm per second, excitation slit at 10 nm, and emission at 
10 nm. 
Single molecule Förster Resonance Energy Transfer. The equipment used was the 
fluorescence microscope. Single molecule FRET (smFRET) is used to measure fluorescence 
intensity of the donor and acceptor fluorescence of a single molecule. The FRET is sensitive to 
the distance between the dyes and therefore, protein structure. And can be used to determine if 
there are any structural changes in the single proteins. The sample has to be diluted a hundred 
times so that the fluorescence of one molecule can be detected. The laser intensity is 610.83 
arbtitrary units which equals about 30 mW and ten traces are collected in two minute intervals. 




E stands for FRET efficiency value (Kuzmenkina, Heyes, & Nienhaus, 2005).  and  
are the acceptor and donor fluorescence intensities (Kuzmenkina, Heyes, & Nienhaus, 2005). 
The gamma is used to correct the different detection efficiencies and the quantum yields of the 
two dyes (Kuzmenkina, Heyes, & Nienhaus, 2005) and has a value of 0.5.  
 
Results and Discussion 
 
Protein unfolding. With the collected data, we were able to identify that the protein 
unfolded at urea concentrations of about 3M so that any buried cysteine residues will be exposed 
to the dyes at urea concentration greater than 3M. Figure 4 (left) shows that as urea is added to 
the protein, the wavelength of tryptophan emission shifts from 345 nm to 356 as the protein 







Protein labeling and gel filtration. The methods were consistently modified in order to 
decrease the number of donor only labeled proteins and to increase the number of the FRET 
labeled proteins. After collecting fractions from the gel filtration, we determined that fraction 
three contained the proteins that were attached to the dyes. There are eight possible outcomes 
when labeling proteins with fluorescent dyes. The protein can be single labeled with just one 
donor dye or one acceptor dye. The protein can also be double labeled with two of the same dyes 
attached the cysteines on one protein. The other possibility is the FRET labeled protein which 
has one of each dye attached to the cysteine groups located on the protein. The graph below 
(figure 5 left) is the absorbance spectrum that was obtained from the UV visible 
spectrophotometer after gel filtration. The absorbance spectra shows the peaks of the labeled 
proteins at the wavelengths 280 nm, 499 nm, and 561 nm which is located  between eluted 
volumes 1 and 2. The peak at elute volume 3 mL shows the absorbance peak for the acceptor dye 
at wavelength 561 nm. The peak located between 4 and 5 shows the absorbance peak of the 
alexa488 at the wavelength 499 nm. This data shows the data from method 4. The graph to the 
right (figure 5 right) shows the absorbance peaks from protein 1 fraction 3 that were used to 
determine the labeling ratio which is shown in the table 3. The peaks in this graph also represent 






















































 Method 1 Method 2 Method 3 Method 4 




The labeling ratio is a comparison of the protein concentration to the concentration of 
donor and acceptor labels. The labeling ratio in methods 1 and 2 were too low in value to note 
any significant changes that occurred by modifying the labeling protocol. In method 1, the dye 
concentrations were the same and they added simultaneously. The concentration of donor only 
labeled and acceptor only labeled proteins were relatively low because the dye concentrations 
were competing to attach to the cysteine group. There was also a low level of FRET labeled 
proteins (see later). By tripling the alexa546 concentration compared to the alexa488 
concentration and increasing the time elapsed between adding the dyes in method 2, the 
concentration of acceptor labeled increased and the concentration of donor labeled proteins 
decreased. In method 3, dye concentrations were the same and the time elapsed between adding 
the dyes was decreased to an hour. There was a significant increase in the concentration of both 
donor and acceptor labeled suggesting more FRET labeled protein. In an effort to decrease the 
donor-only labeled protein, urea was added to the aqueous solution before adding the dyes in 
method 4. This slightly decreased the donor only labeled protein. 
Fluorescence Spectroscopy to measure average FRET. By increasing the alexa546 
concentration to 3 mM and waiting for an hour before adding 1.5 mL of 3mM alexa488, we 
increased the concentration of proteins that were labeled with both fluorescent dyes. The dotted 
lines represent the direct excitation of the acceptor with 485 nm light in both of the graphs below 
that show the average FRET for the labeled sample. By measuring the FRET efficiency of each 
protein (P1 and P2) before and after adding cpSRP54 we found that the FRET efficiency 






























































































Alexa488 and Alexa546 labeled p1 with urea
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 p1_485nm with cpSRP54
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Alexa488 and Alexa546 labeled p2 with urea
 p2_485nm
 p2_485nm with cpSRP54
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Single molecule FRET. Figure 7 shows the single molecule burst data of the single proteins 
labeled with the alexa488 and alexa546 dyes obtained from the fluorescence microscope. The 
peaks that are above the horizontal axis at zero represent the intensity of the donor dye alexa488 
(red). The peaks that below the horizontal axis at zero represent the intensity of the acceptor dye 





These intensities from each burst (single molecule) can then be substituted into the FRET 
efficiency equation below  
 
 
The proteins labeled only with acceptor do not have any significance in the FRET 
histograms because the lasers that are used during the smFRET do not excite the acceptor dyes. 
The donor only labeled proteins are detected in the FRET histogram as a peak centered at zero 
FRET.  
The graphs below show the data that was obtained from the single molecule FRET 
measurements for method 3 without urea (figure 8) and method 4 with Urea (Figure 9). The first 
peak (in green) represents the donor-only labeled protein. The data shows that the addition of 
cpSRP54 increased the FRET efficiency for peak 4 (high FRET) in both protein 1 and protein 2, 
although to a much lower extent in protein 1. Peaks 2, 3, and 4 in the histogram suggests that at 
least three distinct states of cpSRP43 are present, which can only be observed in the smFRET 
experiment. 
The data showed that the ensemble fluorescence and smFRET are consistent in 
measuring the average FRET of the two protein samples. That is to say that the average FRET 
efficiency for P1 and P2 are similar, but that the average FRET efficiency for P2 increases with 


































  Figure 9 
 
Comparing figure 8 and 9 shows that the addition of the urea during the labeling reaction 
increased in the amount of FRET-labeled proteins, and decreased the donor-only labeled 
proteins, which was a major objective of this project. This reduction in the donor-only peak 
allows for less interference (and therefore more confidence) in determining the FRET 
efficiencies and populations of the different protein states. Furthermore, since the difference 
between the FRET efficiency in protein 1 and protein 2 upon addition of cpSRP54 was identical 
from both labeling methods (3 and 4), this shows that using urea for labeling did not permanently 







Urea concentrations above 3M unfolds the protein and exposes both of the cysteines on 
the protein to the fluorescent dyes more so than the cysteines in the folded protein. By modifying 
the labeling protocol to add urea when the donor dye is added, the concentration of FRET 
labeled proteins increased, and the concentration of donor-only proteins decreases. Since both 
proteins P1 and P2 were improved by adding urea, and the cysteine group that is common 
between P1 and P2 is in the Ank2 domain, this suggests it is this ankyrin 2 cysteine that is 
difficult to label, possibly the cysteine residue is not exposed to the solvent when the protein is 
folded. This result highlights the importance of optimizing the labeling protocol for efficient 
labeling of cpSRP43 for FRET studies. 
 The smFRET data showed that there are various states of cpSRP43. The population of 
these states changed as cpSRP54 was added – the higher FRET state was more prevalent when 
cpSRP54 was present. The differences in the smFRET histograms between Ank2-CD2 and 
Ank2-CD3 labeled proteins upon the addition of cpSRP54 suggest that cpSRP54 interacts 
differently with CD2 than CD3. The reasons for these differences are not yet clear, but will be 
the focus of continued studies. For example, future goals will be to investigate the labeling of a 
mutant where the cysteines are placed in CD2 and CD3 and deleted from Ank2. The 
optimization of the labeling protocols described in this report will be invaluable in obtaining high 
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Synthesis and Characterization of a Ru-Pd Bimetallic Complex 





Despite its recent implication as the active catalyst in direct arylation via C-H 
functionalization, little is known about the properties and reactivity of Pd(III).  To address 
this lack of knowledge, Dr. Zheng devised a bimetallic ruthenium-palladium model to 




The area of green, or sustainable, chemistry has become a major research focus as 
scientists try to make improvements for humans and our environment.  Direct arylation via C-H 
functionalization is a specific area within green chemistry that has many advantages over current 
synthesis methods.  By performing chemistry directly on carbon-hydrogen bonds, the need for 
pre-functionalized groups is eliminated.  This allows for developing more efficient synthetic 
methods, eliminating waste and saving time and money. 
Transition metals are often required to functionalize inert C-H bonds, the most common 
being ruthenium, rhodium, and palladium.  A Pd(II)-Pd(IV) redox cycle is typically invoked as 
the accepted mechanism involving palladium as the catalyst for C-H functionalization.  Recently 
though, Pd(III) has been shown to be the active catalyst in direct arylation reactions by Ritter and 
Sanford.3,6  While the reactivity of palladium in its second and fourth oxidation states is well 
understood, palladium in its third oxidation state, only recently being recognized in 
organometallic reactions, has not been studied extensively.  Unlike Pd(IV), which has a 
monomeric octahedral geometry, Pd(III) adopts a dimeric octahedral geometry.7  Reductive 
elimination, the final step in Pd-catalyzed direct arylation, could be greatly affected by this 
geometry difference between Pd(III) and Pd(IV). 
In order to address this lack of knowledge, Dr. Zheng devised a bimetallic ruthenium-
palladium model to specifically study palladium in its third oxidation state.  Since the electron 
transfer between Ru(II) and Ru(III) is strictly a one-electron process, only the desired Pd(III) 
complex is expected to be formed.  The mononuclear Pd(III) complex is expected to be an 
unstable and short-lived species.  Also, preparation of Pd(III) is usually accomplished by 
oxidation of Pd(II) with an external oxidant that is usually incorporated into the final product.  
Discovery of a milder and innocent oxidant would be a major help in broadening the application 
of Pd(III)-catalyzed direct arylation.  By using complex 1.11 as a model, we hope to be able to 




Figure 1. Synthesis Scheme for Ru-Pd complex 
Ru(III) in the presence of viologen.  Then Ru(III) should oxidize Pd(II) to Pd(III), while 
itself is reduced to Ru(II).  This electron transfer process involving the Ru(II) to Ru(III) metal 






All reactions were carried out under an inert atmosphere, mostly nitrogen.  Purification 
was done using flash chromatography or distillation and products were characterized by NMR. 
A) 1.1: Triethyl phosphonoacetate (20.1 mL) was added to NaH (4.34 g) in THF (97 mL) 
at 0°C.  Let warm to room temperature and stir for 30 minutes.  Dissolve 2-bromobenzaldehyde 
(7.9 mL) in THF (97 mL) in a separate flask.  Add the solution of 2-bromobenzaldehyde to 
triethyl phosphonacetate mixture at 0°C.  Stir for 20 minutes at 0°C, then let warm to room 
temperature and stir for 1 hour.  Cool to room temperature and add neat triethyl 
phosphonoacetate (4 mL), then NaH (0.872 g).  Stir at 0°C for 20 minutes, then let warm to room 
temperature and stir for 1 hour.  Quench it with saturated NH4Cl (12 mL) and H2O (10 mL).  
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Extract aqueous layer with EtOAc (2×10 mL).  Washed with H2O (10 mL) and brine (10 mL).  
Concentrate and distill off excess triethyl phosphonoacetate by high vacuum.  Yield: 6.20 g 
(36%).  1H NMR: CH3, 1.34 (t); CH2, 4.29 (q); CH, 6.39 (d); aromatic, 7.19-7.10; CH, 8.05(d). 
B) 1.2: Make slurry of LiAlH4 (1.24 g) in THF (63 mL).  Dissolve 1.1 (2.80 g) in THF 
(63 mL).  Place LiAlH4 slurry in an ice/methanol bath and add 1.1 via syringe.  Stir for 1 hour in 
bath.  Warm to room temperature and stir for 1 hour.  Add H2O (1.3 mL), NaOH (1 mL), and 
H2O (3.6 mL).  Filter through celite with EtOAc and concentrate.  Yield: 1.92 g (82%).  
1H 
NMR: CH2, 1.89(quintet); CH2, 2.81(t); CH2, 3.69(t); aromatic, 7.05-7.58. 
C) 1.3: Add 2-bromopyridine (2.2 mL) and triisopropyl borate (5.8 mL) to 4:1 mixture of 
toluene (90 mL) and THF (23 mL).  Cool to -78°C and added 16 mL of n-BuLi over 30 minutes 
via syringe pump.  Stir at -78°C for 30 minutes, then let warm to room temperature.  Concentrate 
and dry under vacuum at 110°C for 4 hours.  Yield: 5.10 g (83%). 
D) 1.4: Add 1.3 (3.24 g), Pd(dppf)Cl2 (0.145 g), and CsCO3 (2.57 g) to a schlenk flask 
with a side arm.  In glove box, add ZnCl2 (.539 g) and CuCl (.034 g) to the flask.  Dissolve 1.2 
(.848 g) in DMF (40 mL) and transfer to the flask.  Degas the flask via freeze, pump, thaw for 
three cycles.  Stir at 110°C for 19 hours (closed system).  Filter through celite with EtOAc and 
concentrate.  Yield: 0.442 g (53%).  1H NMR: CH2, 1.96(quintet); CH2, 2.85(t); CH2, 3.52(t); 
aromatic, 7.20-8.69. 
E) 1.5: Added Dess-Martin Periodinane (1.44 g) to a flask.  Dissolve 1.4 in CH2Cl2 (16 
mL) and transfer to the flask.  Stir at room temperature for 48 hours.  Dilute with EtOAc (30 mL) 
and partition with 1:1 saturated Na2S2O3 : saturated NaHCO3 (30 mL).  Extract with EtOAc 
(2×15 mL).  Wash with H2O (15 mL) and brine (15 mL) and concentrate.  Yield: .183 g (42%).  
1H NMR: CH2, 2.70(t); CH2, 3.04(t); aromatic, 7.17-8.69; CH, 9.69(s). 
F) 1.7: Mix 1.6 (.401 g) in 48% HBr (8 mL) and concentrated (98%) H2SO4 (0.8 mL).  
Reflux for 3 hours.  Neutralize with saturated Na2CHO3 and filter.  Dissolve product in EtOAc 
and washed with brine.  Dry over Na2SO4 and concentrate.  Immediately start next step.  Crude 
Yield: .365 g (69%) 
G) 1.8: Added neat triethyl phosphite (1.5 mL) to crude 1.7.  Stir at 80°C for 6 hours.  
Distill excess triethyl phosphite.  Crude Yield: .460 g (103%).  1H NMR: CH3, 1.27(t); CH3, 
2.43(s); CH2, 3.22(d); CH2, 4.09(quintet); aromatic, 7.11-8.59. 
H) 1.9: Add KOtBu (.0818 g) to THF (0.5 mL) in glove box.  Dissolve 1.8 in THF (0.5 
mL).  Transfer 1.8 to KOtBu at 0°C and wash with THF (0.5 ml).  Stir at 0°C for 30 minutes.  
Dissolved 1.5 (.051 g) in THF (0.5 mL).  Transfer 1.5 to the flask with 1.8 and wash with THF 
(0.5 mL).  Warm to room temperature and stir for 3 hours.  Quench with H2O (4 drops).  Filter 
with EtOAc.  Partition with H2O (added 1 mL of Hexanes for better partition).  Wash with H2O 
(5 mL).  Extract with EtOAc (3×5 mL).  Wash with brine (5 mL) and concentrate.  Crude Yield: 





Figure 2. a) 1H NMR of 1.8 b) 1H NMR  of 1.9 with leftover 
starting material 1.8 
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Results and Discussion 
 
Problems with the original synthetic scheme prevented us from completing the synthesis 
of complex 1.11, and we were able to get as far as synthesizing 1.9.  The first problem was with 
the Suzuki Miyaura Cross-Coupling.  Initial attempts using Pd2(dba)3 and diphenylphosphine 
oxide as the catalyst resulted in no reaction.  Upon switching to the catalyst system composed of 
Pd(dppf)Cl2, ZnCl2, and CuCl, 1.4 was obtained in 38% yield on the first attempt, and 53% on 
the second attempt.  Oxidation of 1.4 to aldehyde 1.5 also presented problems, as the Swern 
Oxidation yielded only 32%.  Dess-Martin Oxidation yielded a slightly improved 42%.  
Synthesis of 1.8 worked well, with an overall yield of 72%.  Problems again arose with the 
Horner-Wadsworth-Emmons Olefination as original attempts using KHMDS as a base yielded 
mostly one of the starting materials, phosphonate 1.8 while the other starting material, aldehyde 
1.5 decomposed.  When KOtBu was used instead, we were able to synthesize 1.9, but attempts to 





Synthesis of ligand 1.9 was successful.  The problem with purification of 1.9 could be 
easily fixed by using a slight excess of aldehyde 1.5 compared to phosphonoacetate 1.8, as 1.5 
should be easily separated using flash chromatography.  As both the ruthenium and palladium 
metal centers have been extensively studied, we anticipate that steps I and J should be 
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Expression and Purification of Cdc42 and PBD46, a Cancer-Causing 
Combination 





The Ras superfamily consists of low molecular weight G-proteins that are heavily 
involved in cellular signaling, leading to various downstream responses.  Like other Ras 
proteins, Cdc42 (cell division cycle 42) acts as a molecular switch interchanging from its 
active (GTP-bound) and inactive (GDP-bound) state through the utilization of GAP 
(GTPase-activating proteins) and GEF (guanine nucleotide exchange factors) effectors (See 
Figure 1).  It has been shown that Cdc42 signaling pathways play a major role in cell 
proliferation and differentiation leading to tumor growth.  PBD46 is an effector of Cdc42 
proven to inhibit GTP hydrolysis, stabilizing the Ras protein in its active state.  PBD46, as 
well as many other effectors, bind to the Switch I region (amino acids 28-40) of Cdc42.  By 
site-directed mutagenesis, threonine of position 35 was replaced with alanine forming a 
Cdc42 mutant.  With the use of affinity column chromatography, Cdc42(wild type), 
Cdc42(T35A), and PBD46 were expressed and purified for future tests of the Switch I 




Figure 1. The Cdc42 cycle. Cdc42 interchanges from active and inactive states. Other proteins 




Cell division cycle 42 (Cdc42) is a member of the Rho subfamily of small GTPases. 
Typical of Rho proteins, members of this family are heavily involved in cellular activity via 
signal transduction resulting in downstream responses.  Most notably, these responses lead to 
cell proliferation, morphogenesis, and cytoskeletal changes.  Cdc42 functions as a molecular 
switch, cycling between inactive (GDP-bound) and active (GTP-bound) state.  This interchange 
is influenced by guanine nucleotide-exchange factors (GEFs), which replace GDP with GTP on 
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Cdc42, and GTPase-activating proteins (GAPs), which promote GTP hydrolysis to its inactive 
form.  In its inactive state, Cdc42 is not effectively performing signal transduction; however, 
when bound to GTP, Cdc42 can bind to various other effectors, causing downstream signaling.  
 P21 Binding Domain (PBD46) is a 46-amino acid derivative of a p21 activating kinase 
(PAK).  It has been shown that Cdc42 has a high affinity for PAKs.  Particularly, PBD46 inhibits 
the GTP hydrolysis of Cdc42, keeping the protein in its active state and enabling the downstream 
signaling that leads to the formation of tumors.  Therefore, producing the Cdc42-PBD46 
complex allows a means to investigate Rho proteins’ effect on cancer.  
Furthermore, it has been found that PBD46 binds to Cdc42 in its Switch I region, amino 
acids 28-40 (See Figure 2).  It has been documented that threonine is consistently 35th in Rho-
related proteins, indicating that this amino acid is critical for proper function of Cdc42. The 
threonine was mutated to alanine to determine differences in the binding interfaces of 
Cdc42(wild type) and Cdc42(T35A).  This will help determine the purpose of threonine’s 
consistency in Ras proteins.  Proper expression and purification of Cdc42(WT), T35A, and 
PBD46 will enable future tests to compare and contrast the wild type and mutant’s binding 
capabilities. 
 
Figure 2. The first 50 amino acids of Cdc42. The Switch I region is where PBD46 binds to the 
Ras protein. Threonine has been mutated to alanine, making T35A. 
 
Materials and Methods 
 
Protein Expression Cdc42 is expressed in E. Coli strain BL21(DE3) from pET-15b 
vectors as a hexa-histidine tagged protein.  For large scale expressions, Cdc42 was grown in 500 
mL of LB with 0.1 mg/mL ampicillin (same concentration for all LB samples) overnight at 37 
°C. Six flasks of 1.5 liters of LB each were inoculated with 75 mL of the seed culture.  The fresh 
cultures were allowed to grow to an optical density at 600 nm (OD600) in the range of 0.4 – 0.6.  
Ideally, this takes approximately 1 to 1.5 hours.  The cultures were induced with1.0 mM 
isopropyl β-D-thiogalactopyranoside (IPTG) and allowed to incubate for 3.5 hours at 37 °C.  
Then, the cells are centrifuged at 6500 rpm for 15 minutes at 4 °C and washed with a 40 mM 
Tris-base solution.  The cells are centrifuged again, and the pellet is stored at -80 °C until 
needed. 
Before and after induction, 1 mL aliquots were taken from each flask.  These cells were 
spun down by centrifugation at 14000 rpm for 15 minutes at 4 °C.  The pellet was resuspended 
with 120 µL of 8 M urea and stained with 40 µL of 4x loading dye.  The aliquots were incubated 
at 90 °C for 2 – 5 minutes and stored at 4 °C afterwards.  These aliquots were designated for gel 
electrophoresis on 15% sodium dodecyl sulfate (SDS) gels. 
Cdc42(T35A) was expressed in the same manner, but PBD46 had alterations. PBD46 was 
allowed to grow to an OD600 range from 0.8 – 1.0.  Induction was allowed to transpire for 4 to 5 
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hours.  Finally, the PAK was washed with PBS buffer (0.14 M NaCl, 0.0030 M KCl, 0.01 M 
Na2HPO4 x 7 H20, 0.0018M KH2PO4 at pH 7.3) instead of a Tris-base solution. 
Prior to large scale expression, test expressions were performed to guarantee that the 
protein of interest was produced effectively.  This entails a 10-mL overnight culture of protein 
with ampicillin and an inoculation of 500 µL into fresher LB. After uninduced and induced 
samples are taken, the cultures can be properly discarded.  
Protein Purification  Procedures are performed on ice unless otherwise indicated.  The 
stored pellet of Cdc42 was resuspended in a lysis buffer (30 mL Tris binding buffer, 30 mg 
lysozyme, 300 µL Halt Protease Cocktail, 3.5 mg PMSF, with 1 mM GDP per liter of culture 
being resuspended).  Sonicate on ice 5 times for 20 seconds with 1-minute rest periods.  The 
cells were incubated on ice for 30 minutes with occasional stirring.  A small amount of DNase is 
added to the cells, and they incubate at room temperature for 15 minutes.  The cells are 
centrifuged at 19500 rpm for 15 minutes at 4 °C, separating the lysate and pellet.  The lysate is 
filtered, and aliquots of both the supernatant and pellet are taken.  The lysate of Cdc42, being 
kept on ice, is ran over a nickel affinity column on the fast protein liquid chromatography 
(FPLC) machine with Tris binding buffer for nickel column purification (0.040 M imidazole, 
0.100 M NaCl, 0.050 M Tris-HCl, 0.010 M MgCl2 x 6H2O at a pH of 8.0).  The column is coated 
with nickel ions, so the hexa-histidine tag of Cdc42 can bind to it. After running the lysate, the 
higher concentration of imidazole in the elution buffer (0.250 M imidazole, 0.100 M NaCl, 0.050 
M Tris-HCl, 0.010 M MgCl2 x 6H2O at a pH of 8.0) allows for Cdc42 to be purified.  Fragments 
from the suspected Cdc42 absorbance peak are collected for dialysis.  A dialysis (molecular 
weight cut off = 6-8 kDa) of the purified Cdc42 in 5 liters of Tris binding buffer was allowed to 
spin overnight at 4 °C, removing final traces of impurities.  The following day, the absorbance at 
280 nm was taken and the protein concentration of the purified protein was determined using 
Beer’s law. The protein is stored at -80 °C until needed. 
Cdc42(T35A) is purified in the same manner.  The general method of purification is the 
same for PBD46, but there are numerous differences.  For PBD46, 30 mL of PBS buffer is used 
for the lysis buffer instead of Tris binding buffer.  Also, GDP is not added.  Since PBD46 is 
GST-tagged, the column for PBD46 is a glutathione column, allowing the protein to bind via 
disulfide bonds.  The GST-tag must be removed if PBD46 is to form a stable complex with 
Cdc42.  Therefore, after purifying PBD46-GST with GST elution buffer (0.020 M Tris-HCl, 
0.010 M reduced glutathione), the protein is put back on a glutathione column.  Thrombin is 
added to cleave the tag and allowed to rock overnight.  Once the thrombin and PBD46 are 
washed out of the column, the sample solution flows over a heparin column, allowing the 
removal of thrombin.  The purified PBD46 is dialyzed overnight in 5 liters of PBS buffer every 
time it goes across a column.  The concentration of the protein is determined by taking the 




To verify that the protein of interest was actually expressing, gel electrophoresis of 15% 
SDS gels were performed.  SDS gels consist of stacking and separating segments utilized to 
separate proteins based on their size.  Their ingredients include acrylamide, water, SDS, 
tetramethylethylenediamine (TEMED), ammonium persulfate, and a Tris buffer of pH 8.8 for the 
stacking gel and pH 6.8 for the separating gel.  All samples are run alongside a molecular weight 
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marker ranging from 17 to 175 kilodaltons (kDa). This allows experimenters to approximate the 
molecular weight of expressing proteins. 
 
Results and Discussion 
 
 Purification of Cdc42 After the concentration of imidazole was increased on the nickel 
column, an absorbance peak is observed at fragments A4-A7 for the wild type protein, as shown 
in Figure 3.  This is suspected to be Cdc42(WT), so samples of each fragment were taken for gel 
electrophoresis.  Cdc42 is approximately 21 kDa. As indicated on the SDS gel, the samples 
corresponding to the suspected absorbance peak contain proteins of about 21 kDa. Furthermore, 
the significant difference between the lysate and the flow through is also at 21 kDa as expected. 
This verifies that Cdc42(WT) has, in fact, been purified. 
 As indicated above, the T35A mutant is expressed and purified in the same fashion as 
that of the wild type.  Two lysates of the mutant were put on the same column, consecutively. 
When the concentration of imidazole was increased, the T35A absorbance peak is visible on both 
chromatograms as expected.  Both absorbance peaks corresponds to fragments A5-A9, which are 
sampled on the SDS gel. The bands for the pools before and after dialysis indicate that the 
protein is about 21 kDa.  Once again, the most notable difference between the lysate and the flow 
through is a band of approximately 21 kDa.  This leads to a comfortable declaration that T35A 
has also been purified. 
 Purification of PBD46 Altogether, PBD46 goes across 3 columns for purification.  In 
Figure 5, there is a chromatogram of the final step of purification on the heparin column. 
Considering that PBD46 does not have a notable affinity to heparin, it begins to elute instantly in 
fragments A2-A5.  However, concluding that PBD46 has been purified cannot be confirmed with 
the molecular weight marker used. The smallest shown band on the ladder is 17 kDa, but PBD46 
is only 5 kDa.  Although a significant band is shown well below the 17 kDa marker, it is not 
reliable to assume this is the desired protein.  The sample was sent in for MALDI mass 
spectroscopy, but no traces of PBD46 were found. 
 
 




Figure 4. Chromatograms and SDS gel of Cdc42(T35A) purification. 
 
Figure 5. Chromatogram of Heparin column and SDS gel of PBD46 purification. 
 
 
 Protein Concentration After dialysis, the protein concentration of the wild type, the 
mutant, and PBD46 was determined by taking the absorbance at 280 nm of diluted samples. 
Using Beer’s law, the protein concentration was extrapolated from the absorbance values.  The 
concentrations for Cdc42(WT), T35A #1, T35A #2, and PBD46 were 10.7 mg/mL, 2.2 mg/mL, 




With the use of affinity column chromatography, both Cdc42(WT) and T35A have been 
expressed and purified in sufficient amounts to perform assays in the future.  However, there is 
not enough evidence to conclude that PBD46 has been properly isolated.  Even so, 0.1 mg/mL is 




It is essential to purify PBD46 in sufficient amounts to perform experimentation on 
Cdc42 activity.  Ideas for optimizing the isolation of this effector have already been conjured.  A 
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different buffer for the lysis of cells and overnight dialysis may present a better yield.  PBS 
buffer has a pH of 7.3.  However, this pH may be unsuitable for the protein.  Also, it may be 
favorable to use gel beads rather than pre-packed columns.  This will allow for better thrombin 
cleavage.   
After effective purification of the proteins, isothermal titration calorimetry and 
fluorescence tests may be performed to determine thermodynamic data regarding the binding 
affinity of Cdc42 to PBD46.  This will enable affinity comparisons of the Switch I region with 
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Redox-Magnetohydrodynamic Microfluidics Using Multiple Electrode Pairs 
and Sweep-Step Potential Waveforms 





Microfluidics is integral for automating lab-on-a-chip (LOAC) devices, especially if 
it is possible to program fluid flow.  Redox-magnetohydrodynamics (MHD) offers unique 
fluid control for LOAC devices, which is not possible with existing microfluidic pumps.  
The MHD array setup induces fluid flow while eliminating the need for channels, thus 
reducing the complexity of the detection system.  This project addresses a complication 
associated with redox-MHD:  the need for the presence of redox species.  In order to 
minimize interference with a sample and detection, a strategy to immobilize them to the 
electrodes was investigated.  The redox species, hexamine ruthenium chloride, was tethered 
to the electrodes using the polymer Nafion.  Characterization with cyclic voltammetry 
showed that the positively-charged redox species indeed loaded into the negatively-charged 
Nafion polymer (through electrostatic interactions).  Because there is a finite number of 
redox species at the modified electrodes, they will deplete quickly under electrolysis 
conditions.  Thus, a method of redox replenishment was also investigated, but with redox 
species in solution for preliminary studies (0.1 M potassium ferricyanide, 0.1 M potassium 
ferrocyanide in 0.1 M potassium chloride).  A chip was used with an array of individually-
addressable microelectrodes to serve as the anodes and another array to serve as the 
cathodes.  With a multipotentiostat, different pairs of anodes and cathodes were activated 
with a stepped potential (0 V to 0.3 V at the working electrode).  Then at 0.220 s, one set 
underwent a sweep which reversed its potential (in one experiment, a fast sweep over 0.220 
s was used, and in another case a slow sweep over 0.660 s was used).  The sweeps 
replenished the redox species to their original state.  This sequence was performed for 6 
cycles.  The fluid speed was twice as great with both sets during the potential step than 
when one set was swept back.  The results are encouraging that recovery of redox species in 
this manner should be possible.  In the future, the plan is (using another instrument) to 
program a potential waveform using two or more separate active redox-modified electrode 
pairs with the waveforms out of phase of each other, in order to produce a continuous fluid 




There is great interest in microfluidics and LOAC devices that allow for chemical 
analysis on a miniature scale, thus reducing time, materials and power compared to benchtop 
analysis.  Microfluidics is concerned with the control and behavior of liquids that are entrapped 
in a very small area.  These fluids exhibit entirely different properties and behaviors than do 
fluids on a large scale.  This project investigates fundamental properties of redox-
magnetohydrodynamics (redox-MHD) such that it might someday be used to fine-tune 
microfluidic pumping and stirring for LOAC applications. MHD offers some unique capabilities 
to control local fluid motion that other micropumps cannot.1,2  As illustrated in Figure 1a and 1b, 
MHD utilizes a convective force, FB, driven by a magnetic field, B, in the presence of ion 
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current, j.  This convective force in turn directs fluid flow, based on the cross product 
relationship, j B = FB.  This project in particular makes use of the MHD theory in conjunction 
with a silicon microchip with two sets of gold electrode arrays.  Preliminary studies are also 
included using a gold macrochip coated with a polymer film that immobilizes redox species to 
the surface with minimal loss.  It should be noted that programming the potentials at the 
electrodes can oxidize and reduce the redox species, producing j in a controlled manner.  Several 
publications describe this concept.3-6 
 
Figure 1. MHD Theory. The right hand rule dictates the direction of fluid flow between the 
anode and cathode electrode pairs through the array region on the microelectrode chip. The 
magnetic field (B) in this diagram points into the page. The ion flux (j) in this diagram points to 
the right between anode and cathode pairs. The resuting MHD force and consequent fluid flow 
(Flow) thus points upward.  Other j vectors are shown in the array diagrams, pointing away from 
the anodes and toward the cathodes, resulting in the circular flow. 
 
The polymer studies in this project were conducted with the sulfonated fluoropolymer, 
Nafion, and the redox species, hexamine ruthenium (II/III) chloride.  Because of its negative 
charge, the cations in the Nafion are expected to undergo ion exchange with the 
[Ru(NH3)6]
3+/2+.7,8  It is proposed that if the redox species can be tethered to the electrode by 
exchanging into the polymer film, it will be possible to conduct redox-MHD microfluidics 
without the redox species mixing and interfering with the surrounding sample fluid, which has 
been a concern about redox-MHD in the past.  The ion current will be sustained with the aid of 
switching potential waveforms to sequentially activate sets of electrodes in the array, allowing 
previously activated sets to recover when the redox species deplete. 
When a sufficient potential difference is applied between two electrodes in the presence 
of a redox species the anode will cause oxidation (Ru(NH3)
2+ = Ru(NH3)
3+ + e-) and the cathode 
will cause reduction (e- + Ru(NH3)
3+ = Ru(NH3)
2+), creating a current to flow between the 










electrolyte or buffer solution should effectively provide the necessary ions for the ion current in 
solution.  Other studies from our research laboratory have shown that ion current compensation 
from the electrolyte can indeed take place well into the bulk solution between the electrodes. 
These arguments and results suggest that it might only be necessary to place redox species at the 
electrodes (i.e. tethered) for oxidation and reduction, and therefore the redox species will not 
interfere with LOAC samples. 
There are several anticipated challenges with a tethered redox species.  First, appropriate 
redox-species and tethering chemistries must be identified.  Second, the thin layer of tethered 
redox species will deplete in a short time period (estimated 220 ms for a 500 nm Nafion film). 
And third, a switching or potential waveform that allows recovery of redox species is needed. 
For these reasons, this project focuses on the initial investigation of tethering redox 
species at electrode surfaces (results shown here for the sulfonated fluoropolymer Nafion in 
conjunction with the redox species ruthenium hexaamine chloride (Ru(NH3)6Cl3 and 
Ru(NH3)6Cl2)).
7  Also, it explores potential waveforms that should allow for the recovery of 
redox species.  Initial studies are shown here with unmodified electrodes and redox species in 
solution for the same time period and approximate concentrations as expected for modified 
electrodes, varying electrode configuration, timing, potential waveform, and switching. 
When studying the efficiency and effectiveness of LOAC devices that use fluid-flow 
cells, it is necessary to determine the optimal setup for high speed fluid flow.  When the potential 
is stepped past the E0 value in such a system, a transient fluid flow occurs immediately after the 
step but quickly deteriorates over time according the faradaic current flow (which decreases at 
t1/2 as time progresses).  It is also important to note that during fluid-flow experiments, the ideal 
situation is one in which the fluid movement remains swift for a desired period of time.  Due to 
the shortness of time that the transient current occurs and complete depletion for a finite number 
of redox species at an electrode, we require a means of tuning fluid flow in spite of these two 
natural occurrences.  Thus, this project proposes a sweep-step function that will utilize two 
separate sets of anode-cathode pairs of electrodes.  One sweeps from 0.3 V (oxidation) to 0.0 V 
(re-establishing a 1:1 mole ratio of oxidized and reduced forms) and then steps to 0.3 V at 
different times (at the working electrode side of the pair) and for a number of cycles while the 




Chemicals and Materials. All chemicals were reagent grade and used as received.  Aqueous 
solutions were prepared with high purity deionized water from Ricca Chemical Co. (Arlington, 
TX).  Polystyrene latex microspheres (10 µm diameter, 2.5 wt % dispersion in water) and 
ruthenium (II) hexaamine chloride were purchased from Alfa Aesar (Ward Hill, MA). Potassium 
chloride was from VWR (West Chester, PA).  Ultra high purity compressed argon gas was 
obtained from AirGas. Inc. (Radnor, PA). Potassium ferricyanide (K3Fe(CN)6) was purchased 
from EM Science (Gibbstown, NJ) and potassium ferrocyanide trihydrate (K4Fe(CN)6·3H2O) 
was purchased from Aldrich Chemical Co. (St. Louis, MO).  Nafion  perfluorinated ion-
exchange-resin (5 wt% in a mixture of aliphatic alcohol and 45% H2O) was purchased from 






Experimental Setup.  
Configuration 1: For gold macroelectrodes.  To characterize the gold macroelectrodes, a 
3-electrode set up was established using a Ag/AgCl (saturated KCl) reference electrode and Pt 
wire counter electrode.  The working electrode was a 1.3 cm  1.3 cm gold macroelectrode chip 
secured in solution by an alligator clip.  The area of the electrode immersed in the electrolyte was 
1.3 cm x 0.6 cm.  A solution of 0.1 M Ru(NH3)6Cl3 (redox species) in a supporting electrolyte of 
0.1 M KCl was freshly prepared prior to all experiments.  A supporting electrolyte was used to 
minimize the influence of ion migration on the measured faradaic current, it is not electroactive 
in the potential range of interest, and it reduces the resistance to the point where electric fields in 
bulk solution are small.  The CHI 760B potentiostat was used throughout these studies (CH 
Instruments, Austin, TX) to perform cyclic voltammetry (CV) and chronoamperometry (CA). All 
macroelectrodes were stored, covered, at room temperature prior to experimentation.  
Using a Nafion perfluorinated ion-exchange resin, 5 wt% in a mixture of aliphatic 
alcohols and 45% H2O (Sigma Aldrich, St. Louis, MO), gold macrochips (1.3 cm  1.3 cm) were 
spin coated until completely covered by polymer.  In order to ensure a uniform coating, the chip 
was covered with Nafion solution completely before the spin coating cycle was initiated. 
Macrochips were spin coated at 5 different RPM: 1000, 2500, 3500, 4000, and 6000.  Thus, the 
macrochips with the thinnest coating of Nafion were those spun at the fastest RPM, 6000. 
Approximate thicknesses were measured with a Dektak 3030 and are reported in Table 1.  The 
Nafion-coated macroelectrodes were cured for one hour at 80°C and allowed to sit in air, 
covered, at room temperature for two days before experiments. 
 
Nafion Thickness on Macroelectrodes 






Configuration 2: For microelectrode array device.  See Figure 2 for a schematic of the 
setup with the microelectrode array device.  Figure 2a is a photograph of the 20-electrode 
microchip array device.  Prior to MHD experiments, each of the 20 individually addressable 
electrodes were checked by characterization in a solution of 0.1 M KCl, 0.1 M K4Fe(CN)6, and 
0.1 M K3Fe(CN)6.  The characterization experiments utilized a 3-electrode setup was used with a 
gold pseudoreference separate from the array, and a counter electrode which was also separate 
from the array.  Figure 3 shows an overlay of CV responses from one such characterization 
(Chip number CN13).  For MHD experiments, a two-electrode configuration was used with the 
working electrode on one side of the array and the reference and counter leads shorted together 
on the opposite array.  A CHI 1030A multipotentiostat was used to apply the potential 
waveforms throughout MHD experiments.  A 760 µm polydimethylsiloxane (PDMS) gasket was 
placed on the microchip to hold the solution and define the size of the cell (14.0 mm x 6.0 mm). 
The experimental setup is depicted in Figure 2b. 
 
Table 1. The measured 
thicknesses of the Nafion 
polymer on the gold 
macroelectrodes obtained 





Figure 2. Schematic of experimental setup for microchip array redox-MHD experiments.  
(a) Photograph of microchip array device CN4.  The dashed line traces the boundaries of the 
cutout in the PDMS gasket that contains solution (defining cell sidewalls).  The magnet is not 
shown.  (b) Photograph of experimental setup.  The PDMS gasket used to define the 
experimental cell was 760 µm in height, with an inner region cut out (14.0 mm x 6.0 mm).  The 
NdFeB permanent magnet exhibited an average magnetic field of 0.34 T, and was 1.5 inches in 
diameter and 0.5 inches in height. 
 
Sweep-Step Redox-MHD studies.  A CH Instruments 1030A multipotentiostat was used 
in the redox-MHD sweep-step studies.  Working electrode 1 was swept from 0.3 V to 0 V at 1.36 
V/s or 0.45 V/s and then held 0.3 V for 0.220 s.  This sequence was repeated for 6 cycles. 
Working electrode 2 was held at a potential of 0.3 V for the entirety of the two-working 
electrode experiments.  The counter and reference electrodes were shorted together opposite the 
working electrode, on the array region.  The NdFeB permanent magnet used in these studies was 
1.5” in diameter, 0.5” in height, was purchased from Amazing Magnets (Irvine, CA), and 
generates field of 0.34 T, which was measured with a DC Magnetometer.  A Nikon Eclipse 
ME600P microscope was interfaced to a Sony Handycam digital camera (model no. HDR-
XR500V; 30 frames per second with 1920 x 1080 pixels per frame) to record solution 
movement.  Polystyrene latex microspheres (10-µm diameter) were used to visualize solution 
movement.  A fresh redox species-bead mixture (0.04 vol of 2.5% bead solution : 1 vol redox 
solution) was used for each experiment.  Bead speeds were tracked using particle imaging 
velocimetry (PIV) software (DynamicStudio v.3.00 software, Dantec Dynamics).  The PIV 
software is able to take several sequential frames of video and create an average image 
(eliminating background noise) on which the speeds of moving beads are averaged and plotted. 
Video MPG files were converted to single images with 1 step (30 Hz) between each image.  The 
images generated were then imported into the Dantec software and processed via the average 
correlation method.  The speeds in Table 2 were obtained as an average of three separate 
experimental trials. Data was taken from the region on the array only between the active set(s) of 
working electrodes (see designated electrodes in Figures 6 and 8).  Speeds occurred at 300 µm 
above the floor of the cell. The speeds reported for the sweep segments were taken as an average 






































Figure 3. Cyclic Voltammograms of the 
Characterization of Microchip Array 
Device CN13 in redox solution of 0.1 M 
K4Fe(CN)6 and K3Fe(CN)6  in 0.1 M KCl 
showing that the device is functional. 
This figure depicts the peak cathodic and 
anodic currents that occur at each of 18 
individually addressable electrodes in the 
potential window 0.3 V to -0.3 V at 0.05 
V/s, sweeping toward the negative 
potential. On the forward sweep (ipf) the 
Ru(NH3)6Cl
3+  is reduced. On the reverse 
peak (ipr) Ru(NH3)6Cl
2+ is oxidized. 
Cathodic and anodic peaks behave 
similarly for electrodes 2 through 19 on the 
microelectrode array chip (CN13). E° ≈ 0.0 V vs. on-chip gold pseudo-reference electrode. The 
counter electrode was on-chip but also separate from the array. 
 
Results and Discussion 
 
With experimental configuration 1 (for gold macroelectrodes) and subsequent 
experiments, the electrochemistry for each of five different Nafion polymer thicknesses was 
compared using redox species “loading” experiments.  Results showed that the thicker films 
produced more reproducible interactions with [Ru(NH3)6]
3+/2+ solution.  Table 1 shows the five 
speeds at which Nafion polymer was spin coated in addition to corresponding measured 
thicknesses.  Figure 4 illustrates one such “loading” experiment using a gold macrochip that was 
coated with Nafion at 2500 RPM (Nafion thickness at this speed was not measured).  The 
overlay of CV responses in Figure 4 shows the behavior of a Nafion film in three sequential 
experiments: (1) the expected background current in 0.1 M KCl electrolyte alone before loading, 
(2) diffusion-limited current from redox species in solution during loading, and (3) expected shift 
in E1/2 due to stabilization of oxidized form loaded in negatively-charged Nafion.  Because of 
this shift, we see that there are electrostatic interactions between the Nafion polymer and the 











As can be seen in Figure 4, the 0.1 M KCl (the supporting electrolyte in the Ru(NH3)6Cl3 
solution) is negligible.  There is a peak that occurs from approximately -0.3 V to -0.4 V, but this 
is due to the reduction of oxygen in solution.  Preliminary studies with the redox-polymer 
combination shown here indicate that the combination does exhibit tethering to the electrode 
surface, thus it is promising for decreasing interference in redox-MHD future studies.  More 
work needs to be done in determining the best redox-modfied electrodes suitable for redox-MHD 
microfluidics. 
These polymer studies, however, segued to the investigation of tuning fluid flow and 
redox species replenishment at the electrode array region, again using the array chip depicted in 
Figure 2a in the experimental setup depicted in Figure 2b.  To this end, a series of studies were 
performed in solution containing redox species using different potential waveforms.  Two 
waveform combinations were utilized, one for short sweep-step studies (Figure 5) and another 
for long sweep-step studies (Figure 7).  Images obtained using PIV analysis of videos (Figures 6 
and 8) allowed for the comparison of bead speeds for control experiments and for experiments 
utilizing one and two pairs of active electrodes, separately. 


















(1) 0.1 M KCl (before loading) 






 in 0.1 M KCl (loading)
(3) 0.1 M KCl (after loading)
Figure 4.  Nafion-Coated Gold Macroelectrode 
studies. This overlay of CV responses shows the 





Figure 5.  Waveform Diagram 





Two Electrode Pairs 





































Figure 6. PIV Analyses for Short Sweep-Step Studies. During these experiments, the 
sweep across potential window 0.3 V to 0.0 V (towards more negative potentials) was 
programmed to last 0.220 s at 1.36 V/s for 6 sequential cycles. The large dark arrows were 
overlayed to represent the net fluid flow in the region between active electrodes. Speeds 
(Table 2) from greatest to least were measured: 3A>1A, 4A>2A. 
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Figure 8. Long Sweep-Step Studies. The working electrode is opposite a counter electrode 
shorted to the reference electrode, all on the array region.  During these experiments, the sweep 
across potential window 0.3 V to 0.0 V (towards more negative potentials) was programmed to 
last 0.660 s at 0.45 V/s for 6 sequential cycles.  The large dark arrows were overlayed to 
represent the region between active electrodes.  Speeds (Table 2) from greatest to least were 
measured: 3B>1B, 4B>2B. 
 
PIV analysis of the control experiments, which employed only one working electrode 
pair (with the counter electrode and reference electrode shorted together on the opposite array as 
indicated) are shown in Figures 6 and 8 (1A, 2A, 1B, and 2B).  Speeds are reported in Table 2.  
The average bead speed was measured from the region of the array only between active 
electrodes and at a height of 300 µm from the floor of the cell.  During the step part of the cycle 
(1A and 1B), fluid flow occurs between active electrodes in a fairly flat flow profile.  For the 
sweep part of the cycle (2A and 2B), the beads slow to a stop when going from +0.3 V to 0.0 V. 
This was expected because the current is lower during the slower sweep.  Then, at 0.0 V, a 1:1 
Controls 
Two Electrode Pairs 



































mole ratio of oxidized-to-reduced forms is produced (E = E°) and that is the starting composition 
of the solution, thus no net current is generated.  Without any current, |j| = 0 and therefore |FB| = 
0 and velocity of the fluid is zero. 
In experiments utilizing two sets of electrode pairs (3A and 3B), the combined step 
produces twice the fluid speed of that for a single set of paired electrodes in the control 
experiments.  This was expected to occur with twice the active electrodes and twice the current 
and with reinforcing flow enhancement.  When the W1 electrode set begins its sweep (4A and 
4B), the fluid slows to half the speed but continues to flow, because the W2 set of electrodes 
continues to produce a current at the 0.3 V potential step, as expected. 
 
Bead Speed During Sweep-Step Studies 
Experiment Speed* / µm·s-1 
1A 113.1 ± 19.8 
2A 41.3 ± 20.0 
3A 232.3 ± 19.9 
4A 105.3 ± 21.5 
1B 120.6 ± 1.6 
2B 14.3 ± 7.1 
3B 234.0 ± 18.7 
4B 108.8 ± 20.8 
 
Thus, it is observed that fluid continues to flow while alternating electrodes are swept to 
recover redox species.  In addition to increasing the time that the species has to replenish, a 
longer sweep time allows more electrode sets to be included with sweep-step functions that are 
out of phase with each other to ensure continuous fluid flow over long times.  When future 
studies include more functions out of phase with one another, different instrumentation must be 
used.  A diagram of the ideal waveform sequence has been drawn in Figure 9.  Again, this setup 
will allow electrodes the be stepped while others are sweeping to allow for continuous 
replenishment of species. 
 
 
Figure 9. Waveform diagram intended for future studies with a different instrument.  
Table 2. Bead Speeds for Sweep-Step 
Studies (corresponding to experiments 
labeled in Figure 6 and 8). The bead speeds 
occurred as predicted.  Fluid flow was greater 
during sweep-step experiments with the 
second working electrode held at a potential 
than during sweep-step experiments with a 
second electrode at open circuit.  *Speeds are 
averages calculated from three experimental 






The sweep-step studies investigated here show that fluid flow is increased by twofold as 
the number of electrode pairs is doubled.  This suggests that the maximum velocity can be tuned 
to a specific application by increasing or decreasing the number of electrode pairs that are 
activated simultaneously.  The current during a sweep decreases with time, and likewise beads 
slow to a stop as the sweep progresses in both the short and long sweep studies.  Thus, the 
working electrodes that are sweeping decrease their contribution to the overall fluid flow.  As 
long as other electrode pairs are activated with a step, fluid continues to flow, but at a lower 
velocity.   
If new electrode pairs are stepped to oxidizing potentials only when old electrode pairs 
begin their sweep-recovery cycle, then the fluid should achieve a fairly constant velocity with 
small pulses at the switching times.  However, this kind of switching will require modification 
and reprogramming of existing instrumentation.  In the future, we hope to be able to create 
waveforms such as the one pictured in Figure 9, where cycles are performed on multiple pairs of 
electrodes, out of phase with one another, allowing for continued pumping of fluid at some 
electrodes while replenishment of redox species occurs at others.  The cycles will be repeated 
such that fluid flow is sustained over long periods of time.  Also in the future, work needs to be 
done to tether redox species to electrodes.  There was not enough time to investigate the 
Nafion/Ru(NH3)6
3+/2+ system thoroughly.  Many other possible systems are reported in the 
literature.  However, the most optimized conditions will be those where redox species are 
covalently attached to avoid loss into surrounding fluid, films are as thin as possible to maximize 
electron transfer and diffusion rates (e.g. monolayer), and redox concentrations are high to 
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Chemical Synthesis of PdxFey-Pt Nanoparticles as Electrocatalysts 





Platinum (Pt) catalysts used in fuel cells are in need of much improvement, 
especially regarding the oxidation reduction reaction (ORR) on the cathode side of the fuel 
cell.  An approach designed to reduce the amount of Pt used and enhance the catalytic 
ability of the catalysts is described, using a core-shell structure with a palladium-iron alloy 
as a core and Pt as the shell.  Nanoparticles made of mainly Pd with trace amount of Fe 
were synthesized using combination of thermal decomposition and reduction in the 
presence of different capping ligands.  The initial attempt to make core-shell structures is 




The fuel cell has become the object of much interest due to its ability to convert chemical 
energy directly into electricity.  In the fuel cell, fuel is separated from oxygen by an electrolyte 
membrane.  At the anode of the fuel cell, fuel is oxidized as it comes in contact with a catalyst 
(H2 2H+ + 2e-).  The proton travels across the electrolyte membrane while the electrons travel 
through an external circuit.  At the cathode side, the oxygen reduction reaction (ORR) takes 
place.  Oxygen reacts with the electrons and protons, forming water (½O2 + 2e
- + 2H+ H2O). 
The catalysts for these reactions are generally Platinum (Pt), Pt-based alloys, or carbon-
supported catalysts (Pt/C).  The catalyst at the anode can have low Pt amounts without 
performance loss1; however, slower kinetics at the cathode requires the use of much more 
platinum2.  This is an issue because of the rarity and the cost of Pt.  The problem is that OH tends 
to adsorb strongly to the catalyst, blocking the oxygen from reaching it3. 
There are several ways to overcome this problem.  The surface of a catalyst is what 
catalyzes a reaction, and the different facets of a crystal catalyst have different catalytic abilities. 
The ORR of a Pt octahedron enclosed by {111} is higher than cube enclosed by {100}3,4,5.  The 
reason is the OH adsorption on the crystal surface on the {111} plane is less than on the {100} 
plane, allowing more oxygen to access the surface of the catalyst3.  Also, alloying Pt with 3d-
transition metals (e.g. Fe, Ni, or Co) amplifies catalytic ability due to electron coupling2,5.  Noble 
metals, such as gold, silver and palladium, can enhance the ORR activity by balancing the 
strength of adsorption of O and OH. A Pt/Pd alloy is expected to have a very high ORR activity6. 
To reduce the amount of Pt used, a core-shell structure can be a potential solution, where only 
the surface of the nanocrystal consists of Pt. In this work, attempts were made to synthesize core 




Chemicals. Palladium (II) acetylacetonate (Pd(acac)2, Pd 34.7%), platinum (II) acetylacetonate 
(Pt(acac)2 Pt 48.0%), potassium tetrachloroplatinate (II) (K2PtCl4, 99.9%, Pt 46.0%), iron (II) 
chloride tetrahydrate (FeCl2·4H2O, 99%), iron (II) stearate (Fe(St)2, Fe 9%), stearic acid (HSt, 
90%), tetramethylammonium hydroxide (TMAOH, 25% w/w in methanol), iron (III) chloride 
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hexahydrate (FeCl3·6H2O, 97-102%), oleic acid (OA, 90%), 1-octadecene (ODE, 90%), and iron 
pentacarbonyl (Fe(CO)5 ,99.99%) were purchased from Alfa Aesar.  Iron (III) acetylacetonate 
(Fe(acac)3, 99+%) and tungsten hexacarbonyl (W(CO)6, 99%) were purchased from Acros 
Organics.  Oleylamine (OLA, 70%) was purchased from Aldrich.  Tri-n-octylphosphine (TOP, 
90%) was purchased from TCI America.  All chemicals were used as received without further 
purification. 
Synthesis Methods.  
1. Synthesis of Iron (III) stearate. In a beaker, 5.0 mmol FeCl3·6H2O was added to 6.3 mL of 
methanol and stirred until dissolved.  Then 15.0 mmol of HSt was added to the solution and 
methanol was added for a total of about 30 mL of methanol.  The solution was then heated to 
boiling and all of the HSt was dissolved.  Afterward, 15.0 mmol of TMAOH was added by slow 
squirting, and dark, red-brown clumps formed.  The solution was kept at 30°C for 30 minutes to 
allow the reaction to complete.  The gummy product was washed with boiling methanol in a 
Buchner funnel.  The product was analyzed using an FT-IR and was washed until the peak at 
~1740 cm-1 from the carbonyl in HSt was no longer visible. 
2. Synthesis of sample 1.  Into a three-neck flask, 0.05 mmol of FeCl2·4H2O and 0.05 mmol of 
Pd(acac)2 were loaded with 6.0 mL of OLA.  The flask was degassed to remove oxygen using a 
flow of argon for 10 minutes at room temperature (RT), and it was stirred vigorously for the 
remainder of the experiment.  The temperature was then set to 130 °C.  In a separate vial, 0.05 g 
of W(CO)6 (~1.4 mmol) was added to 2.0 mL of OA and 2.0 mL of OLA and degassed under 
argon.  Using heating, shaking and ultrasonication, the W(CO)6 was dissolved in the vial forming 
a bright lime colored solution.  When the three-neck flask reached 130 °C, the solution in the vial 
was injected into the flask via a glass syringe.  The solution in the three-neck flask was then set 
to 240 °C and allowed to react for 20 minutes.  The flask was removed from heat and allowed to 
cool to RT.  The product was then washed twice using methanol, centrifuging at 4,000 RPM, and 
removing the supernatant.  It was then washed four more times in a similar way using a small 
amount of toluene with the methanol. 
3. Synthesis of sample 2.  For this reaction, 0.05 mmol of Fe(St)2 was used as the iron precursor 
instead of FeCl2·4H2O, and the reaction at 240 °C went for 45 minutes. All other experimental 
conditions remained the same as the synthesis for Sample 1.  
4. Synthesis of sample 3.  For this reaction, 0.05 mmol of Fe(acac)3 was used as the iron 
precursor.  All other experimental conditions remained the same as the synthesis for Sample 2. 
5. Synthesis of sample 4.  For this reaction, 0.05 mmol of synthesized Fe(St)3 was used as the 
iron precursor.  All other experimental conditions remained the same as the synthesis for Sample 
2. 
6. Synthesis of sample 5.  In a three-neck flask, 0.05 mmol Pd(acac)2 was added along with 2.0 
mL of OA, 2.0 mL of OLA, and 4.0 mL of ODE.  It was degassed under a flow of argon for 10 
minutes.  Then 1.0 mL of TOP was injected and the flask was degassed for 30 minutes. 
Following this, 0.4 mmol of Fe(CO)5 in 1.0 mL of ODE was injected into the flask, and it was 
degassed for 30 minutes.  The flask was set to 300 °C and reacted at that temperature for 30 
minutes.  It was then removed from heat and cooled to RT.  The product was washed in a similar 
manner as described in the synthesis of Sample 1.  
7. Addition of Pt to sample 5.  As-synthesized sample 5 was put in a three-neck flask with 4.0 
mL of OLA and 4.0 mL of ODE.  Then 0.05 mmol of K2PtCl4 was added.  The flask was 
degassed under argon at RT for 30 minutes, then reacted at 100 °C for two hours.  The reddish Pt 
precursor was still visible, so the flask temperature was increased to 200 °C and reacted for 90 
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minutes.  As an alternative method, K2PtCl4 was added to 4.0 mL of OLA in a three-neck flask 
and stirred under argon at RT.  Then it was slowly heated to 75 °C to attempt to dissolve it under 
vigorous stirring, and cooled to RT.  Sample 5 was added to 4.0 mL of ODE and injected into the 
flask.  It was subsequently raised to 160 °C for 1 hour.  It was then washed in a similar manner as 
described in the synthesis for Sample 1, except acetone was used instead of methanol. 
Characterization Method.  X-ray diffraction (XRD) patterns were collected using a Rigaku 
Miniflex II X-ray diffractometer equipped with a Cu Kα radiation source (λ = 1.5406 Å) 
operating at 30 kV/15 mA.  Transmission electron microscope (TEM) images were taken on a 
Fei Titan 80-300 microscope with an accelerating voltage of 300 kV. Infrared spectra were 
obtained using a Bruker Tensor 27 FT-IR spectrometer. 
 
Results and Discussion 
 
The nanoparticles made of Pd and Fe were synthesized using various iron precursors in 
an organic solution of OLA and OA.  Both can serve as capping ligands for nanocrystals, and 
OLA also serves as a reducing agent5.  Figure 1 shows the TEM images of the nanocrystals 
prepared in samples 1-4.  The nanoparticles noticeably aggregated in a toluene solution and they 





Figure 1.  TEM images of nanocrystals made of Pd and Fe as synthsized from different iron 
precursors: (A) iron (II) chloride tetrahydrate, (B) iron (II) stearate, (C) iron (III) acetylacetonate, 
and (D) iron (III) stearate. 
 
Figure 2 shows the XRD pattern of samples 1-4.  The first two samples look virtually the 
same, exhibiting peaks that are quite consistent with face-centered cubic (fcc) crystal structure, 
similar to Pd.  The slight shift of the peak position is attributed to the composition of Fe (4%) in 
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the nanoparticles.  The black vertical bars represent the relative position and peaks of that alloy. 
Samples 3 and 4 show a few other peaks that are not consistent with a Pd/Fe alloy.  The peak at 
23 degrees is indicative of an iron oxide, hematite (Fe2O3).  The peaks around 30, 54, and 63 
degrees are from other type of iron oxide, magnetite (Fe3O4).  This result suggested that there are 




Figure 2.  XRD patterns of palladium-iron nanoparticles prepared from different precursors:  A) 
iron (II) chloride, B) iron (II) stearate, C) iron (III) acetylacetonate, and D) iron (III) stearate. 




Figure 3.  IR spectra of the ligands on the four samples compared with oleic acid (OA) and 
oleylamine (OLA).  Samples were prepared using various iron precursors, A) iron (II) chloride, 
B) iron (II) stearate, C) iron (III) acetylacetonate, and D) iron (III) stearate.  The chart on the 





Two possible capping agents were used in the synthesis of these nanoparticles.  To 
determine whether OLA and/or OA were the actual capping ligand, the samples were analyzed 
using FT-IR.  Figure 3 shows the IR spectra of samples 1 through 4, along with OLA and OA as 
control. The peak assignments were listed in Table 1.  The peaks at ~2853 and ~2922 cm-1 are 
due to the symmetric and asymmetric CH2 stretching modes
7,8. The peak at 1710 cm-1 for the OA 
is from the C=O stretching8.  The peak at 1710 cm-1 is missing in the samples, while the peaks at 
~1651 and ~1384 cm-1 are present in the samples.  Both of these two peaks arise from the 
asymmetric and symmetric vibration of the metal carboxylate7 which is typically in the range of 
1650-1510 cm-1 and 1400-1280 cm-1, respectively9.  The peak at ~1460 cm-1 may also be due to 
the symmetric stretching of the carboxylate group8.  This result implies that the nanoparticles in 
all samples were capped by OA.  The peak at 3320 cm-1 for OLA is from –NH stretching which 
is also disappeared in all the samples possibly due to the amine group on the OLA bound to the 
surface of nanoparticles. 
 
Table 1.  IR peak assignment 
Peak (cm-1) Assignment 
3320 NH stretch 
2922 CH2 asymmetric stretch 
1710 CH2 symmetric stretch 
1651 C=O metal asymmetric stretch 
1460 COO- symmetric stretch 
1384 COO- metal symmetric stretch 
 
The Pd/Fe nanoparticles were also synthesized using TOP as capping ligand.  These 
nanoparticles were very uniform spheres which were used for Pt coating.  The reactions were 
performed at high temperature and low temperature.  Figure 4 shows the typical TEM images of 
the products.  At high temperature, the reduction was very fast.  As a result, the reduced Pt atoms 
were self-nucleated and formed large agglomerates.  At low temperature, the reduction slowed 
down and fewer agglomerates were found in the production.  However, in both cases, no Pt shell 
was deposited on the core particles.  This is possibly due to two main reasons:  1) the hinderance 
of the capping ligand on the nanoparticles blocking the Pt atom diffusion onto their surfaces, and 
2) the fast reduction kinetics promoting the self-nucleation of the Pt nanoparticles. 
 
   
 
Figure 4.  TEM images of Pd/Fe nanoparticles with the addition of Pt at two different 







Nanoparticles made of Pd and Fe were synthesized in solution phase reaction with 
different capping ligands.  The crystal structures were characterized by XRD. The products were 
dominated by Pd component.  Depending on the types of Fe precursors, the final products may 
contain iron oxide impurities.  The initial attempt to make core-shell structures is unsuccessful 
due to the self-nucleation of Pt.  Future work includes optimization of the core morphology and 
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Digestive Enzyme Analysis of Rheb (Ras homolog enriched brain) 
Ja’Qualane Scales, Philander Smith College 
Little Rock, Arkansas 
 
Abstract 
Ras homolog enriched brain [Homo sapiens] is a gene consisting of 183 amino acids 
and a molecular weight of 20.7 kDa.  It is a member of the GTPase superfamily and it 
encodes proteins that are bound to lipids in the cell membrane.  Some of the major 
functions of this protein are cell proliferation, cell differentiation and regulation of growth 
due to its interaction with mTOR/S6K1/4E-BP1 signaling transduction pathway.  The 
protein has GTPase capabilities and switches between a GDP-form and a GTP-form, which 
is made possible through phosphorylation, dephosphorylation, and farnesylation ("Rheb 
ras homolog," 2011).  Protein farnesylation plays an essential role in the membrane and the 
interaction between most eukaryotic proteins.  In addition, it is catalyzed by the enzyme 
farnesyltransferase (FTIs).  Current research has brought attention to the biological affects 
farnesylation may have on cancer cells, actin cytoskeleton, and cell morphology (F., & CL, 
2001).  Proteolytic digestions with chymotrypsin and trypsin were used on Rheb-His6 and 





Rheb binds and activates mTORC1, a metabolic regulator that is vital to cancer cells.  
Studies have shown that Rheb assists in different stages of cancer development through various 
tumor-induced mechanisms.  These mechanisms may be contributed to late prognosis of patients 
with cancer overexpressing Rheb.  However, there has not been enough sufficient research done 
to link Rheb with cancer pathogenesis (Lu, 2010).   
 
mTOR/S6K1/4E-BP1  
The signaling protein TOR (target of rapamycin; other common names in mammals are 
FRAP, RAFT, or RAPT) is classified in the superfamily of phosphatidylinositol kinase-related 
kinase and it controls cell growth and the cell cycle from yeast to flies to mammals.  The 
mammalian target of rapamycin (mTOR) uses nutrients and mitogen signals to control the 
growth and division of cells.  Rapamycin reduces the cells and mTOR keeps the cell from being 
reduced.  Therefore, TOR signaling controls cell growth and cell size.  Two signaling pathways 
that work in conjunction to control mRNA translation also have a dual role as downstream 
effectors of mTOR.  These effectors are ribosomal protein S6 kinase 1 (S6K1) pathway and the 
eukaryotic translation initiation factor 4E (Eif4E)-binding protein 1 (4E-BP1 or PHAS-I)/eIF4E 
pathway (Fingar, 2003).  Many researchers suggest that S6K1 plays a vital role in the S-phase of 
the cell cycle.  On the other hand, 4EBP1/eIF4E does not have a critical role in the cell cycle 
progression but it is overexpressed in human tumors.  S6K1 and eIF4E pathways function 
separately to increase cell size along mTOR and it promotes mTOR-dependent cell cycle 






Protein purification isolates and breaks down large individual proteins into fragments that 
can be used to examine protein activity.  Proteins can function as enzymes, signals, or receptors.  
In addition, they play a role in gene expression.  Purification is a process that includes three 
stages:  fractionation, purification, and polishing.  Fractionation is a preparation step and the 
beginning of reduction steps.  During fractionation, proteins are being separated using a 
centrifuge, microfilter system, or lysis buffer. The purification step continues to break down the 
protein and eliminates contaminants by using chromatography.  The purpose of chromatography 
is to separate different cell constituents using chemicals.  Polishing removes parts of the protein 




Enzymes are highly energized proteins that catalyze biological systems and determine 
chemical changes (Berg, Tymoczko, & Stryer, 2007).  They are specific and bind to particular 
active sites. These protein molecules are required for the digestion of food, brain stimulation, and 
producing cellular energy.  Digestive enzymes are found in the gastrointestinal tract and their 
purpose is to break down food so nutrients can be extracted and absorbed easily.  Also, enzymes 
are present in raw foods and they aid in starting the digestion process, which lowers the amount 
of digestive enzymes secreted.  When cooking at moderate to high temperatures, food enzymes 
get destroyed.  However, if the body has to constantly rely on its own enzymes; more stress will 
be put on the biological system (“Digestive Enzymes”).   
There are numerous proteolytic enzymes that help break down proteins in the digestive 
system.  Chymotrypsin is an example of a digestive enzyme that slices peptide bonds specifically 
on the carboxyl-terminal (C-terminal) side of the hydrophobic and aromatic amino acids, such as 
phenylalanine and methionine.  In addition, chymotrypsin is an example of using covalent 
catalysis because the nucelophile becomes covalently attached to the substrates’ unreactive 
carbonyl carbon.  Trypsin is another amino acid that slices peptides on the C-terminal side of 
lysine and arginine amino acid deposits (Worthington, 2009). 
Digestive enzymes are important because they work together as catalysts to aid in 
absorption and digestion.  Enzymes are essential to the body because without them food would 




Test Expression and Protein Purification 
 First, two 1L and one 250ml flasks of LB media were made and autoclaved for an hour 
[1L water: 25.0g LB media; 250ml water: 6.3g LB media ]. Then, the flasks cooled down for 30 
minutes.  Next, 250µl of ampicillin was pipetted into the 250ml flask and 1ml of the Rheb-His6 
protein was pipetted into the same flask.  After, the flask was placed on a shaker (370C) 
overnight.  The next day the O.D. was measured and the formula [ ∗ . . 0.05  was 
used to calculate how much protein should be used to inoculate the fresh LB media.  Then, 1ml 
of ampicillin was pipetted into both 1L flasks.  Next, both flasks were inoculated with the 
calculated amount of proteins and then placed on a shaker until the cells reached an O.D. 
between 0.6-0.8.  After, a 120µl aliquot (add 20µl 8M urea and 40µl 4xSDS Loading Dye) was 
taken and labeled (Rui).  Then, 400ml of the protein was taken from one of the 1L flasks and 
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placed in an eppendorf tube.  The tube was balanced and spun on maximum in an eppendorf 
microfuge for 15 minutes.  Next, the supernatant was poured into the biohazard trash bin with 
only the pellet left in the eppendorf tube.  The pellet was resuspended in urea (120µl) and 40µl 
of loading dye was added.  Then, the eppendorf tube was placed in the VWR incubator for 2 
minutes at 900C.  Next, the eppendorf tube was labeled (Ri ) and stored at -80
0C.  Later, 200µl of 
IPTG was placed in both 1L flasks and incubated at room temperature for 4-5 hours.  Next, the 
cells from the two 1L flasks were poured into 6 centrifuge bottles and balanced.  Then, the cells 
were centrifuged (6500rpm, 15mins, 40C).  After, the supernatant was discarded and the pellets 
were left in the bottles.  Next, the cells were resuspended in Binding Buffer for PBS-Ni2+ -
Affinity Purification.  40ml of the buffer was poured into a beaker and 5ml of the buffer was 
pipetted into each of the 6 bottles.  Then, the cells were poured into a 50ml tube, balanced, and 
centrifuged (Jouan centrifuge) for 15 minutes.  After, the supernatant was discarded and the 
pellets were placed in a -800C freezer (not necessary if continuing the procedure).  Later, fresh 
lysis buffer was made and placed on ice, while the cells unthawed on top of the ice for an hour.  
Next, the cells were resuspended in fresh lysis buffer.  Then, the cells were sonicated 5 times for 
20 seconds with 1 minute intervals while still in ice.  After, the lysate was incubated on ice for 
30 minutes.  During the incubation period, the FPLC was cleaned.  Next, a small scoop of 
DNAse was added to the lysate and incubated for 15 minutes at room temperature.  Then, the 
lysate was poured into a tube, balanced, and centrifuged (19500rpm, 15 minutes, 40C).  After, the 
supernatant and pellet were filtered.  Next, an aliquot of the supernatant and the pellet was taken 
[small scoop of supernatant (RL=Rheb lysate); pellet+60µl of 8M urea (Rp=Rheb pellet); added 
40µl of 4 x Loading Dye to each].  After, the lysate ran over Ni2+-Affinity Column on the FPLC.  
Next, an aliquot of the flow through (RFT) and Pool Fractions (Rpool) were taken.  The aliquots 
were placed in a freezer at -800C and the sample was placed in a tube and refrigerated.  Later, a 
15% SDS gel was loaded and ran (200V, 65mA, 60mins).  Then, a dialysis of pure Rheb was 
done in 1xPBS-Buffer+0.010M MgCl2 x 6 H20 overnight at 4
0C (MWCO Dialysis Bag=6000-
8000 kDa).  Later, the protein content was determined.  Then, the protein was concentrated and 
an aliquot was taken.  
 
Digestive Enzyme Assay 
First, 2mg/ml of chymotrypsin was made.  Then, 7 eppendorf tubes were labeled (0 minutes, 
1 minute, 5 minutes, 10 minutes, 20 minutes, 30 minutes., 60 minutes).  Next, chymotrypsin to 
Rheb-His6 concentrations (1:10 ratio) was calculated for incubation.  Then, an aliquot of Rheb 
and chymotrypsin (30µl of Rheb and 30µl of chymotrypsin; 10µl of 4 x loading dye in each) was 
taken and frozen immediately.  After, 500µl of Rheb and 970µl of chymotrypsin were incubated 
at room temperature in a water bath for 5 minutes.  Next, the calculated amount of chymotrypsin 
to Rheb sample was made and then the extra chymotrypsin was frozen immediately.  Then, the 
Rheb/Chymotrypsin sample was incubated in time intervals of 0 minutes, 1 minute, 5 minutes, 
10 minutes, 20 minutes, 30 minutes, and 60 minutes.  After each time interval was reached, 30 µl 
of the sample was placed into the desired eppendorf tube. Then, 10 µl of the 4 x loading dye was 
added and the eppendorf tube was placed in liquid nitrogen.  Lastly, a 15% SDS gel was made 




Results and Discussion 
   
Figure 1:  Rheb GTPase Cycle in cell-cycle regulation 
 
   
Figure 2. Purification of Rheb-His6 protein. A, chromatogram from the purification of Rheb-His6; B, 15% 
SDS-GEL analysis of fractions from the purification of Rheb-His6.  Lane 1, molecular weight marker (kDa); 
lane 2, uninduced Rheb; lane 3, induced Rheb; lane 4, protein pellet; lane 5, supernatant; lane 6, flow-through 





Figure 3. Chymotrypsin. Gel electrophoresis of chymotrypsin assay. Lane 1, molecular weight maker (kDa). 
Lane 2, Rheb. Lane 3, Chymotrypsin. Lane 4, 0 minutes. Lane 5, 1 minute. Lane 6, 5 minutes. Lane 7, 10 
minutes. Lane 8,  20 minutes. Lane 9, 30 minutes. Lane 10, 60 minutes.  
 
Figure 4. Trypsin. Gel electrophoresis of trypsin assay. Lane 1, molecular weight maker (kDa). Lane 2, Rheb. 
Lane 3, Trypsin. Lane 4, 0 minutes. Lane 5, 1 minute. Lane 6, 5 minutes. Lane 7, 10 minutes. Lane 8, 20 
minutes. Lane 9,  30 minutes. Lane 10, 60 minutes.  
The digestive enzyme assay was repeated three times to gain better results.  Of the four 
assays, one produced quality results.  According to the chymotrypsin SDS-Gel, Rheb was 
completely digested at zero minutes.  However, the trypsin SDS-GEL showed evidence of some 
fragmentation, even though the intensities of the Rheb bands were not significantly different.  
Overall, these results show that the ratio of chymotrypsin to Rheb was too low and the 





The objective of this project was completed but more research is needed to understand 
the affects chymotrypsin and trypsin has on Rheb.  Also, a minor change in the methodology is 
suggested to produce better results.  However, future research studies will be targeted towards 
analyzing protein patterns and protein interactions; labeling small fragments of the protein that 
have been cleaved by digestive enzymes; and using fluorescent dye as a control to compare the 
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Tailoring Polymer-Coated Gold Nanocages for Chemical Sampling in a 
Microdialysis Device 





Gold (Au) nanocages have extensive biomedical applications.  The polymer poly-N-
isopropylacrylamide (p-(NIPAAm)) is a thermally responsive polymer that can change its 
structural conformations with change in temperature with respect to its low critical 
solution temperature (LCST).  Gold nanocages with localized surface plasmon resonance 
(LSPR) tuned near IR region are coated with p-(NIPAAm) and this polymer controls the 
release of samples from nanocages with the temperature change.  Besides other biomedical 
applications of p-(NIPAAm) coated nanocages such as drug delivery, photoacoustic 
imaging, photothermal therapy, and contrast agent, this preliminary study was done to 
demonstrate as proof of principle if these nanocages can be used for chemical sampling 
through microdialysis device.  Microdialysis sampling is a minimally invasive device that 
collects samples via diffusion from different tissues and organs with aid of semipermeable 
hollow fiber membrane.  The analyte diffuse into the semipermeable membrane and 
carried out by perfusion fluid for further chemical analysis.  The main objective of our 
study is to demonstrate if p-(NIPAAm) coated gold nanocages passed in the perfusion fluid 
could collect analytes through microdialysis sampling.  Our study results showed that p-





Gold (Au) nanoparticles have been the part of intensive biomedical applications such as 
chemotherapy, photothermal therapy, and optical imaging.  Gold nanocages are the 
nanostructures prepared by galvanic replacement reaction where a gold salt precursor 
(chloroauric acid) is titrated into a solution of sacrificial silver (Ag) nanocube suspension.1  The 
interior part of Ag nanostructure is oxidized and reduced Au atoms grow on the surface of 
nanocubes producing Au nanocages.5  Au nanocages have porous walls and a hollow interior 
with unique tunable localized surface plasmon resonance (LSPR) varying the size of nanocages 
and their pores.  For biomedical applications, LSPR peak of Au nanocages should be tuned to 
near infrared region.1  Thermally sensitive polymers poly (N-isopropylacrylamide) (p-
(NIPAAm)) with low critical solution temperature (LCST) of 32oC are used to coat the Au 
nanocages.  When temperature is below LCST, the polymer is hydrophilic in nature and when 
temperature is above LCST, the polymer becomes hydrophobic.2This polymer is heat-sensitive 
and its conformation changes with temperature with respect to its LCST.3  Polymer coated 
nanocages at temperature above LCST results in shrinking of hydrodynamic diameter of polymer 
leading to exposure of pores of nancoages, and thus releasing samples from the core or 
entrapping samples inside the core.  Temperature below LCST causes polymer to stretch out and 
covers the pores of nanocages and thus restricting the movement of samples through the pores. 
This conformational change of polymer controls the release of samples from Au nanocages.  So 
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we attempt to use polymer coated nanocages as carrier for chemical sampling using 
microdialysis device. 
Microdialysis sampling is a minimally invasive device that helps to collect samples via 
diffusion from different tissues and organs of the body for biochemical studies.  It is a simple in-
vivo technique of collecting samples with the aid of probe consisting of semipermeable hollow 
fiber membrane with 200-500 μm diameter and 1-30mm length inserted into the different tissues 
and organs.4  The analytes diffuse through the semipermeable membrane and they are carried out 
through outlet impermeable membrane as dialysate.  Detection of dialysate can be quantified in 
mathematical expression called extraction effienciency (EE) which is the ratio of the 
concentration of analyte extracted from microdialysis sampling (Coutlet) to that of analyte stock 
(Cinlet) as expressed in equation 1.
6 
																																																																		 % 	 																																																												1	 
 
Extraction efficiency of chemical sampling depends on the perfusion flow rate, 
concentration of perfusion fluid and analyte, diffusion coefficient of analyte, and molecular 
weight cut off (MWCO), material, and pore size of membrane.  Microdialysis sampling has been 
applied in many areas of neuroscience and biotechnology.  A microdialysis probe has shown 
promising adaptation to diversified applications, and samples analysis that are easily done by 
available technologies.  So our vision is to use polymer coated nanocages for chemical sampling 
using the microdialysis probe as shown in Figure 1.  At temperature above LCST of polymer, 
polymer coated Au nanocages inside microdialysis membrane can entrap diffused analyte into its 
core and entrapped analyte can be further analyzed.  The main objective of this study is to 










Synthesisof Ag nanocubes:  Ethylene glycol (EG), 50 mL was heated to 150oC and 
stirred.  At 150oC, EG solutions of 0.6 mL of 3mM NaHS, 5 mL of 3 mM HCl, and 12.5 mL of 
Polyvinylpyrrolidone (PVP) (0.35 g PVP dissolved in 17.5 mL) were added to the solution.  
After 2 mins, 4 mL of silver trifluoroacetate in EG solution (282) mM was added to the reaction 
mixture and heated for 35-45 mins at 150oC. 
Synthesis of Au nanocages:  Deionized water in 100 mL round bottom flask was heated 
and stirred for 10 mins.  500 μL of Ag nanocube suspension was added to water.  Chloroauric 
acid (HAuCl4) solution (1 mM) was titrated to the Ag nanocube solution.  The UV-Vis spectrum 
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of the sample was taken.  NaCl crystals were added to sample until the solution saturated and 
stored for an hour.  The sample was centrifuged at 14000 rpm for 15 mins and clear solution was 
discarded.  The sample was redispersed with 1.5 mL water and washed twice.  The sample was 
resuspended by 0.1 mL water. 
Surface coating of Au nanocages by p- (NIPAAm):  Thermally responsive polymer p-
(NIPAAm) (MW~12,000) (10 mL of 0.33 mM) with LCST 32oC was titrated by 5 mL of 1.6 nM 
Au nanocages at the rate of 0.2 mL/min.  The reaction solution was stirred for 5 days at room 
temperature.  The polymer coated nanocages was centrifuged at 14000 rpm for 15 mins at 20oC 
and supernatant was discarded.  The nanocages were washed 4 times and it was resuspended 
with 0.6 mL deionized water.  For the controlled release of dye, copolymer p-(NIPAAm-co-
AAm) (poly-N-isopropylacrylamide-co-acrylamide) with LCST 41oC was used for surface 
coating of Au nanocages. 
Loading of Rhodamine B (RB) dye in copolymer coated Au nanocages:  The 
suspended copolymer coated Au nanocages (0.6 mL)was mixed with 10 mL of RB dye (~18 
mM) and it was vortexed and sonicated for 10 mins.  It was placed in oil bath at 50oC overnight. 
The solution was placed in ice bath for an hour.  It was centrifuged at 14000 rpm for 15 mins at 
20oC and supernatant was discarded.  The solution was washed until the absorbance of 
supernatant at 554 nm was less than 0.05. 
RB dye release from copolymer coated Au nanocages:  RB dye loaded copolymer 
coated nanocages were suspended with 0.6 mL warm water (50oC) and vortexed.  It was placed 
in water bath at 50oC for 2 mins and immediately placed in ice bath for 5 mins.  It was 
centrifuged at 14000 rpm for 15 mins at 20oC and UV-Vis spectrum reading of supernatant was 
taken.  After absorbance reading, supernatant was returned back to the nanocages and again it 
was placed in water bath for next time intervals of conventional heating. 
Microdialysis Sampling:  The microdialysis setup is shown in Figure 1 and 2.  Polymer 
p-(NIPAAm) coated Au nanocages ranging the concentration from µM to nM were used as 
perfusion fluid in the microdialysis sampling.  The semipermeable membrane was immersed in 
the analyte solution (dyes) and the flow rate of perfusion fluid was adjusted depending on the 
experimental setup.  The concentration of analyte used was in the range of µM.  The 
microdialysis probe used was PES (Polyethersulfone) of 100 kDa.  Chemical sampling was 
carried out in two different conditions: placing microdialysis probe along with analyte in sand 
bath (37-40oC) and placing microdialysis setup in warm room (37oC). 
Instrumentation:  Transmission electron microscope (TEM) images were taken on a FEI 
Titan 80-300 microscope with an accelerating voltage of 300 kV.  The UV-vis spectra were 
obtained using a UV-vis spectrometer (HP 8453A).  The hydrodynamic diameter was measured 













Figure 3: (Left) Microdialysis sampling set up and (Right)Microdialysis probe. 
 
 
Results and Discussion 
 
Gold nanocages were synthesized by galvanic replacement reaction such that reduced Au 
replaces the oxidized Ag atoms.  When Ag nanocube suspension is titrated with gold salt 
solution precursor (HAuCl4), Ag atoms get oxidized which dealloys the Ag/Au nanostructures 
and changes the structural composition of Ag nanocubes into Ag nanocages.  With the increase 
in titrated volume of HAuCl4 solution into the Ag nanocube suspension, there was a red shifting 
of LSPR peak to near IR region and the observation of series of color change from yellow, 
orange, maroon, purple, navy blue to fading blue (Figure 4).  The LSPR peak of Au nanocages 
can be tuned to desired wavelength and for this experimental purpose there was requirement of 
LSPR peak to be tuned near IR region (780-800 nm).  Most of Au nanocages synthesized had 






Figure 4: Tuning of LSPR peaks of Au nanocages at different wavelengths:  (Left) UV-Vis 
spectra of samples prepared by different titrated volumes of HAuCl4 solution were taken.  With 
the increase of titrated volume of HAuCl4 solution on Ag nanocube suspension, the LSPR peak 
wavelength red shifted.  (Right) Photograph of the sample solution (going from left to right) with 
the increase in titrated volume of HAuCl4 solution on Ag nanocube suspended solution. 
 
 
Figure 5 shows the TEM image of p-(NIPAAm) coated Au nanocages and the UV-Vis 
spectra for both PVP-coated and p-(NIPAAm) coated Au nanocages.  The size of the nanocages 
is 40±5 nm.  There was observation of red-shifting of LSPR peak after replacing PVP polymer 
by p-(NIPAAm) on surface of Au nanocages.  In order to further confirm the exchange of PVP 
polymer by p-(NIPAAm) polymer on the surface of Au nanocages as well as to observe the 
change of hydrodynamic diameter of p-(NIPAAm) coated Au nanocages above and below its 
LCST (32oC), the DLS experiment was carried out (Figure 6).  At two different temperatures, 25 
oC and 37oC, the change of diameter of p-(NIPAAm) coated nanocages was observed unlike 
PVP coated nanocages. The PVP coated nanocages exhibited negligible change in diameter with 
temperature change whereas, p-(NIPAAm) coating showed significant changes such that above 
LCST (37oC) diameter decreased (shrinked) and it reversibly expanded below LCST (25oC) as 
shown in Figure 6.  At 37 oC, the hydrodynamic diameter of the nanocages was measured to be 





Figure 5: (Left) TEM imageof p-(NIPAAm) coated Au nanocages and (Right) Red-shifting of 
LSPR peak with the change of polymer coated on Au nanocages. LSPR peak of PVP nanocages 






























p‐NIPAAm covered nanocages PVP‐covered nanocages
 
Figure 6: Observation of diameter change with change in temperature with respect to LCST of 
polymer p-(NIPAAm). 
 
Gold nanocages with LPSR peak at near IR region were coated with thermally responsive 
copolymer p-(NIPAAm-co-AAm) having LCST 41oC.  The RB dye (~18mM) was loaded on 
copolymer coated Au nanocages in order to figure out how the temperature affects the release of 
dye from the nanocages and also to check the functionality of nanocages as shown in Figure 7.  It 
was observed through UV-Vis spectra of supernatant at 554 nm that with the increase in time 
intervals of conventional heating beyond LCST of copolymer, there was increase in the amount 
of RB dye released from the nanocages.  The copolymer has the LCST 41oC so when copolymer 
coated nanocages was placed in water bath of 50oC at certain time intervals, copolymer shrinks 




Figure 7: Controlled release of RB dye from copolymer coated Au nanocages with LCST 
41oC:  Absorption spectra of RB dye released at 554 nm were measured for different time 
intervals of conventional heating.  It demonstrated that the higher time interval of heating of RB 
dye loaded nanocages, the more release of dye from nanocages. 
 
Microdialysis sampling was carried out using methyl orange dye (MO) and p-(NIPAAm) 
nanocages of concentration 16.7 M.  The absorbance peak of MO dye is at 465 nm.  The 
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microdialysis probe was immersed in the analyte MO stock solution.  The analyte was placed in 
sand bath at temperature 40oC.  Flow rate of perfusion fluid is one of the important factor to 
affect the extraction efficiency (EE%) of chemical sampling.  As shown in Table 1, EE% of 
analyte sampling increased with the decrease in the flow rate of perfusion fluid.  Maximum EE% 
could be achieved using slow perfusion flow rate because it allows more time for diffused 
analyte to get entrapped or adsorbed by polymer coated nanocages. 
 

























MO 20.3 1.4 6.8 - ~100 
 
 
For the next experimental set-up, 1 L/min perfusion flow rate was used.  Microdialysis 
sampling was carried out in warm room at 37oC temperature using p-(NIPAAm) coated 
nanocages (0.1 nM) and water (control) as perfusion fluid, as shown in Table 2.The EE% of 
microdialysis sampling using p-(NIPAAm) nanocages as perfusion fluid was less than using 
water (Control).  The possible reason might be due to not being able to detect the dye entrapped 
inside the nanocages.  But the results demonstrated that p-(NIPAAm) nanocages can be used in 
microdialysis sampling in order to collect analyte comparing the EE% of chemical sampling 
using p-(NIPAAm) coated nanocages versus water.  These nanocages can be applied in 
microdialysis sampling without probe damage as they are recovered completely through outlet. 
 


















pNIPAAmnanocages MO 16.8 5.6 33.2 0.7 ~100 
Water MO 21.9 9.1 41.4 1.3 Not 
measured 
  
To determine the non-specific adsorption of dye on the p-(NIPAAm) coated nanocages, 
the control experiments were performed at room temperature.  The result in Table 3 shows that a 
small amount of MO dye was lost when the MO solution was incubated with the p-(NIPAAm) 





Table 3. Non-specific adsorption of dye on p-(NIPAAm) coated nanocages. 
Temperature(oC) MO stock (μM) MO in supernatant (μM) MO loss (μM) 




 The p-(NIPAAm) coated nanocages can be used for the collection of samples through 
microdialysis sampling.  There is no damage of microdialysis probe because of these nanocages 
are fully recovered through microdialysis probe.  The results of this study showed that the 
extraction efficiency of analyte using p-(NIPAAm) nanocages as perfusion fluid increased with 
the decrease in perfusion flow rate.  On the other hand, the extraction efficiency of analyte using 
perfusion p-(NIPAAm)nanocages is less compared to water (control).  The possible reason might 
be due to the dye entrapped inside the nanocages.  Further experiments need to be carried out to 
quantify the entrapped dye by releasing them from the nanocages.  As per our objective, p-
(NIPAAm) coated nanocages can be used as perfusion fluid to carry out chemical sampling.  The 
sampling efficiency of microdialysis can be optimized by concentration, porosity, and coating 
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Expanding the Scope of the Catalytic Dynamic Resolution of N-Boc-2-
Lithiopiperidine 
Jin Sun Woo, Mount Holyoke College 
South Hadley, Massachusetts 
Abstract 
The scope of the catalytic dynamic resolution (CDR) of N-Boc-2-lithiopiperidine 1 has been 





1. 10 mol % 2, -45 oC, 3 h












Optically active piperidine derivatives are prevalent in natural products and are used in 
thousands of clinical and preclinical trials.1  For example, (-)-swainsonine is a potentially useful 
antimetastasis drug for cancer treatment,2 and conhydrine is a poisonous alkaloid in hemlock3 
(Figure 1). The pipecolic moiety is a key structure in antamiscomicin B4.  The enantioselective 
synthesis of piperidine derivatives has been the subject of investigation by many researchers.5 
Recently, Beng and Gawley discovered a catalytic dynamic resolution (CDR) of N-Boc-2-
lithiopiperidine using dilithiated diamino alkoxide ligands (S,S)-2 and (S,R)-2, which afford 
either enantiomer of the 2-substituted piperidine in good yields and excellent enantioselectivity6 
(Scheme 1).  In small scale reactions (<5 mmol), the authors synthesized both enantiomers of the 
proline homologue, pipecolic acid as well as the ester and amide derivatives in >97:3 er.  In the 
wake of the important finding, there is a growing interest in implementing the CDR methodology 
as an alternative to a classical resolution, which is still the most practical way to obtain 
enantiopure compounds on an industrial scale.  
  




































































The goal of this project was to synthesize multigram quantities of enantioenriched 
pipecolic acid or its derivatives, for use in the total synthesis of antascomicin B. 
 
Results and Discussion 
 As the starting material, N-Boc-piperidine was prepared by the reaction of di-tert-butyl 
dicarbonate and piperidine in dichloromethane (Scheme 2).  24.30 g of the desired product was 
obtained as an oil in 100% yield, data as reported.6 









Toward the synthesis of (S,R)-2, the (S,R)-dipeptide ester 4 was synthesized by peptide 
coupling reaction of (S)-N-Boc-leucine and D-proline methyl ester hydrochloride in the presence 
of EDCI and HOBt in chloroform (Scheme 3).  1.26 g (76%) of the dipeptide ester was obtained.  
The reduction of the dipeptide ester was followed. 1.15 g of the conjugate acid of crude (S,R)-2 
was obtained as viscous oil. 
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EDCI (1 equiv), HOBt (1 equiv)













 The conjugate acid of diastereomeric ligand (S,S)-2 was also synthesized in the same 
way, to give 0.56 g (71%) of the product. 
 R-3 was synthesized by CDR using ligand (S,S)-2 (Scheme 4).  After deprotonation of N-
Boc-piperidine using s-BuLi and TMEDA at –80 oC for 3 h, the addition of 10 mol% of (S,S)-2 
and 3 h of equilibration were followed.  After cooling to –80 oC, methyl chloroformate was 
added. CSP-GC traces showed one peak thus indicating that enantiopure R-3 was obtained.  
 





1. s-BuLi, 4 equiv TMEDA, -80 oC, 3 h
2. 10 mol % (S,S)-2, -45 oC, 3 h





To a 250 mL round bottom flask containing piperidine (9.89 g, 131.5 mmol, 1.0 equiv), di-tert-
butyl dicarbonate (28.7 g, 131.5 mmol, 1.0 equiv) in CH2Cl2 (100 mL) was added slowly by 
dropping funnel at 0 °C.  The mixture was stirred for 3h and washed with saturated NaCl (3 x 
50mL) and with H2O (2 x 50 mL).  The combined organic layers were dried over MgSO4 and 
filtered and evaporated. 
 
Conjugate acid of (S,R)-2. 
Step 1.  Boc-(L)-leucine (2.12 g, 4.83 mmol, 1.0 equiv) was dissolved in CHCl3 (20 mL) in 100 
mL round bottom flask.  EDCI (0.95 g, 4.83 mmol, 1.0 equiv) and HOBt (0.73 g, 4.83 mmol, 1.0 
equiv) were added.  The mixture was stirred for 10 min. D-Pro-OMeHCl (0.80 g, 4.83 mmol, 
1.0 equiv) in CHCl3 (10 mL) and Et3N (2 mL) was added to the mixture slowly.  The mixture 
was stirred at room temperature for 10 h.  The solvents were evaporated.  Ethylacetate (10 mL) 
was added, and the mixture was stirred for 30 min.  The suspension was filtered.  The filtrate was 
washed with10% citric acid (3 x 10 mL) and with 10% NaHCO3 (2 x 10 mL).  The organic layer 
was dried over MgSO4 and evaporated. 
Step 2.  A stirred suspension of LiAlH4 (1.4 g, 36.80 mmol, 10.0 equiv) in THF (100 mL) was 
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cooled to 0 oC. A solution of the (S,R)-4 (1.26 g, 3.68 mmol, 1.0 equiv) in THF (30 mL) was 
added dropwise to the suspension.  The mixture was stirred for 10 min at room temperature and 
refluxed for 16 h.  The mixture was cooled to 0 oC and Et2O (50 mL) was added.  The mixture 
was carefully quenched by slow addition of 50% NaOH(aq) (100 mL) while stirring until all salts 
appeared white.  The solvent was decanted, and the white solid was washed with Et2O.  The 
combined organic layers were dried over MgSO4 and evaporated. The crude was purified by 
Kugelrohr distillation. 
 





NMR spectra of (S,S)-2 
 
 
Synthesis of R-3. 
In an oven-dried, septum-capped 25 mL round bottom flask equipped with a stir bar, N-Boc-
piperidine (0.185 g, 1 mmol, 1 equiv) and freshly distilled TMEDA (.15 ml, 4 mmol, 4.0 equiv) 
were dissolved in freshly distilled Et2O (10 mL) under argon.  The solution was cooled to –80 °C 
and s-BuLi (1.2 equiv) was added slowly by means of a syringe over a ten minute period.  The 
mixture was stirred for 3 h.  The conjugate acid of (S,S)-2 (0.022 g, 0.1 mmol, 10 mol%) in Et2O 
(10 mL) was treated with freshly titrated s-BuLi (20 mol%).  The preformed alkoxide S,S-2 was 
added and the flask was quickly transferred to a second thermostatted bath at –45 °C, and 
allowed to stir for 3 h.  The mixture was cooled to –80 °C and rapidly quenched with methyl 
chloroformate (0.23 mL, 3 mmol, 3.0 equiv).  After 2 h, MeOH was added and the mixture was 
stirred for 5 min.  After warming to room temperature, 2 M HCl was added.  The layers were 
separated and the aqueous layer was extracted with Et2O.  The combined organic layers were 
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Synthesis of JWH-018 Metabolite 





Beginning in 2004, herbal mixtures with the name “Spice” or “K2” were sold in 
“headshops” and on the internet.  These mixtures contain 1-pentyl-3-(1-napthoyl)indole, 
also known as JWH-018.  Although JWH-018 and delta-9-tetrahydrocannabinol (Δ9-THC) 
have different structures, both give cannabis-like effects after consumption.  Hallucination, 
distorted perception, and tachycardia are common effects of usage.  Due to this, the Drug 
Enforcement Agency (DEA) is conducting further studies to determine if these mixtures 
should be permanently placed on the controlled substances list prohibiting their sale and 
consumption.  For this project, the authors synthesized a JWH-018 metabolite and 
analyzed the products using gas chromatography-mass spectroscopy (GC/MS).  The 
metabolite was synthesized to mimic the metabolized product found in K2 users’ urine 
after its consumption.  Hydroxylation on the alkyl chain is the most common metabolite 
found in urine; therefore, the authors choose to synthesize it to act as an analytical 
standard to compare to urine samples of K2 users.  Since the carboxylic acid form is the 





 In 2004, interest in herbal mixtures with the names “K2” and “Spice” became apparent as 
these blends began appearing in “headshops” and online.  Although some of these mixtures come 
in packages with warnings suggesting that they are not for human consumption (Figure 1), the 
mixtures have been used as “herbal highs.” 
The most common ingredient reported in these mixtures is 1-pentyl-3-(1-napthoyl)indole, 
also known as JWH-018.  While JWH-018 has cannabis-like effects similar to delta-9-
tetrahydrocannabinol (Δ9-THC) found in marijuana, they do not have similar structures (Figure 
2).  Both of these substances interact with the cannabinoid receptors, CB1 and CB2, with a higher 
binding affinity reported for JWH-018 compared to Δ
9-THC [1,2]. Less JWH-018 is, therefore, 
needed in the body to have the same effects as a higher dose of Δ9-THC.  Hallucination, distorted 
perception, and tachycardia are common effects of usage for JWH-018 and Δ9-THC. 
Previous studies of JWH-018 have included detection in incense packets using GC/MS 
[3].  These studies have allowed these mixtures to be monitored before they become available on 
the market.  Determining appropriate methods for detecting metabolic products is beneficial for 
law enforcement agencies.  This is especially applicable since the Drug Enforcement Agency 
(DEA) is conducting studies to determine if mixtures containing JWH-018 should be placed on 
the controlled substances list prohibiting their sales [4]. 
 The purpose of this study is to synthesize a JWH-018 metabolite where hydroxylation 
occurs on the alkyl chain.  This is the most common metabolite predicted in K2 users’ urine by 
studies with rat liver microsomes reported by Wintermeyer et al [5].  The synthesized metabolite 
will then be used as an analytical standard to quantitate the metabolite found in K2 users’ urine. 
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The presence of this metabolite has only recently been confirmed with liquid 
chromatography-mass spectrometry (LC-MS/MS) [6].  Developing a GC/MS method and 
improving the method validation is needed for conclusive determination of a history of abuse.  
Since previous studies in the group have shown that better detection limits are achieved 
when the metabolite is derivatized with the same protecting groups used in the synthesis, the 
synthetic target of this study was the silane derivative shown in Figure 3.  The overall synthetic 
scheme can be found in Figure 3 with the different reagents and conditions regarding each step.  
In further studies, the removal of the protecting group and addition of the hydroxyl group will 
take place.  This will allow the hydroxyl group to be oxidized into a carboxylic acid which is the 




Figure 1. Different brands of ‘Spice’ herbal products illustrating differences in packaging and 









 Materials and Instrumentation.  The solvents and reagents were purchased from EMD 
Chemicals (Gibbstown, NJ), Sigma Aldrich (St. Louis, MO), and TCI America (Portland, OR).  
The samples were analyzed using a Varian 450 gas chromatography system combined with a 
Varian 320 MS.  The GC had an injector temperature fixed at 300 °C, a split 10:1 ratio, and a 
Zebron ZB-5HT Inferno 30M x 0.25 ID column.  The temperature programming of the GC 
varied for the steps.  Steps 1 and 2 were held at 65 °C (2 min) then increased with a rate of 25 
°C/min until 280 °C (2 min).  For step 3, the temperature was held at 80°C then increased at a 
rate of 25 °C/min to reach 310 °C (15 min).  The MS conditions were as follows: scanning 50-
500 amu and 1 sec/scan. 
 Compound 1 (1-t-butyldimethylsilyl-5-bromopentane).  5-bromo-pentan-1-ol (3.6 mL, 
29.7 mmole), imidazole (5.1 g, 74.9 mmole), and tert-butyldimethylsilyl chloride (TBDMSCL) 
(5.9 g, 39.1 mmole) were dissolved in 10 mL DMF under N2 at 0 °C.  The reaction stirred 
overnight at room temperature.  After the overnight reaction, the solution was diluted with 20 
mL ethanol and quenched with 10 mL 1 M HCl.  The clear, colorless solution was extracted 
three times with petroleum ether (50 mL), dried with Na2SO4, and filtered.  The petroleum ether 
was removed by rotary evaporation and a clear oil (compound 1) was recovered and purified 
using a silica column (petroleum ether/ethanol, 50:1 v/v) [7]. 
 Compound 2 (1-(5-t-butyldimethylsilylpentyl)indole).  Compound 1 (8.0 g, 28.5 
mmol), KOH (0.5 g, 8.9 mmol), and 1.1 g indole (1.1 g, 9.4 mmol) were dissolved in 20 mL 
DMF and the reaction was stirred overnight.  The mixture was quenched after this time with 50 
mL H2O.  After the addition of H2O, the solution formed a white precipitate with an orange oil 
on top of the solution.  The solution was extracted three times with petroleum ether (50 mL), 
washed three times with H2O (50 mL), dried with MgSO4, and filtered.  Rotary evaporation was 
used to remove the petroleum ether which was followed by purification by a silica column 
(petroleum ether/diethyl ether, 9:1 v/v) [8]. 
 Compound 3 (1-(5-t-butyldimethylsilylpentyl)-3-(napthoyl)indole)..   Compound 2 
(0.7 g, 2.2 mmol) was dissolved in CH2Cl2 (10 mL, 156.6 mmol) and cooled to 0 °C under N2.  
To this solution, Me2AlCl (3.4 mL, 36.6 mmol) was added drop-wise and allowed to stir for 30 
min.  After this time, 1-naphthoyl chloride (0.4 mL, 2.6 mmol) was added in dry CH2Cl2 (10 mL, 
156.6 mmol) to the pink solution and stirred for 2 hrs. After the solution changed to a bright 
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orange color, DMF was removed by rotary evaporation to recover a brown oil. The oil was 





Figure 3.  Reagents and conditions for the synthesis of JWH-018 hydroxylated metabolite; (a) 
TBDMSCl, imidazole, DMF, 0°C to room temperature; (b) DMF, indole, KOH; and (c) 1-
naphthoyl chloride, CH2Cl2, Me2AlCl, 0°C. 
 
Results and Discussion 
 
 During the synthesis of the JWH-018 metabolite, each compound was analyzed using 
GC/MS to confirm product formation.  The gas chromatogram, corresponding mass spectrum, 
and fragmentation pattern were determined for each product. 
 The GC/MS data and fragmentation patterns for compound 1 are shown in Figures 4. 
Compound 1 should have a molecular ion at m/z 281; however, this ion is not visible in the mass 
spectrum (Figure 4B).  In previous studies by this group, chemical ionization (CI) was used for 
confirmation.  In this instance, a molecular ion at m/z 281 was observed.  The current GC/MS 
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method uses electron ionization (EI) which did not fragment the compound in the same manner. 
EI uses a hard ionization technique, whereas, CI is often referred to as a soft ionization 
technique.  EI may cause rearrangement of the chain to form a cyclic structure. A cyclic structure 




Figure 4. (A) GC chromatogram of compound 1; and (B) corresponding MS spectrum. 
 
 It appears that compound 1 fragments in the MS to form an ion at m/z 166 as illustrated in 




Figure 5. Fragmentation patterns of compound 1. 
 
The product was also analyzed by 1H NMR.  Peak assignments for compound 1 are 
shown in Figure 6 and are labeled in the NMR spectrum (Figure 7) as follows:  peaks 1 and 5 are 
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triplets, peak 2 is a pentet, peaks 6 and 7 are singlets and peaks 3 and 4 is an unresolved 
multiplet.  These assignments correspond to those predicted thus confirming product formation. 
 
  





Figure 7. (A) H1 NMR of compound 1; (B) enlarged view of spectrum A centered around 1.2-
3.4 ppm. 
 
 The GC/MS and fragmentation patterns of compound 2 are shown in Figure 8.  The 
molecular ion of compound 2 is found at m/z 317 and is visible in the mass spectrum (Figure 
8B).  Other abundant ions are found at m/z 130 and m/z 260.  These ion formations indicate that 






Figure 8. (A) GC chromatogram of compound 2; and (B) corresponding MS spectrum. 
 
 The fragmentation patterns of compound 2 are shown in Figure 9.  The ion at m/z 130 is 
formed through loss of the butyl side chain and protecting group (-.(CH2)4OSi(CH3)2C(CH3)3).  
The ion at m/z 260 is formed from loss of the tert butyl on the protecting group (-.C(CH3)3).  
 
 
Figure 9. Fragmentation patterns of compound 2. 
 
 The GC/MS data and fragmentation patterns for compound 3 are visible in Figure 10.  
Compound 3 has a molecular ion at m/z 471 visible in the mass spectrum (Figure 10B).  The 





Figure 10. (A) GC chromatogram of compound 3; and (B) corresponding MS spectrum. 
 
The ions at m/z 127 and 155 are from naphthalenyl and carbonylnaphthalenyl, 
respectively.  Another abundant ion is at m/z 414, which corresponds to loss of tert butyl from 
the protecting group (-.C(CH3)3).  This loss is identical to the loss found in compound 2 at m/z 








 In conclusion, the JWH-018 metabolite was formed with the protecting group attached in 
place of the hydroxyl group (Figure 3 compound 3).  This proved to have better detection limits 
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with GC/MS than the hydroxylated form of the metabolite.  The appropriate GC/MS 
methodology was determined during this project which will help in future studies regarding this 
metabolite.  Proper analytical standards are crucial to compare the standard retention time and 




 In future studies, the synthesis will be continued to form the hydroxylated metabolite 
which can then be oxidized to form the carboxylic acid.  Both metabolites will then be compared 
to those found in K2 users’ urine.  After the hydroxylated metabolite is formed, the detection 
limits of the metabolite will be determined. In addition, future work will compare the methods of 
GC/MS to the established one for LC-MS/MS.  As a result of the gas chromatogram and mass 
spectrum of compound 1 using EI, future studies will also analyze different brominated alkyl 
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